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1. ABSTRACT 
Neuronal ceroid lipofuscinoses (NCL) are degenerative disorders of childhood, which 
affect the central nervous system (CNS). NCL belong to the wider group of lysosomal 
storage diseases and they are characterized by the accumulation of endo-lysosomal 
material with specific ultrastructural features, both in neuronal cells and other peripheral 
tissues. NCL arise from either primary or secondary involvement of the lysosomal 
compartment, since mutated NCL proteins reside not only in the lysosomes but also in 
other cellular structures, such as the endoplasmic reticulum.  
Over last 30 year ten NCL forms have been identified according to clinical, pathological 
and molecular criteria; moreover, eight NCL genes have been cloned, coding for proteins 
of specific and different functions. Therefore, today, NCL represents the acronym of a 
group of genetically different disorders of the CNS, leading to progressive shrinkage of the 
brain. 
The main issue in the NCL pathology is the comprehension of which cellular 
mechanisms are involved in neuronal cell death in these conditions. Recently the attention 
has been addressed mainly to the pathogenetic role that the abnormal storage may exert on 
the cellular homeostasis and survival, even through apoptotic cell death. Moreover, a role 
for autophagy is also under scrutiny, since morphological and molecular evidences suggest 
the activation of this cellular mechanism both in humans and animal models of disease.  
The aim of this doctorate project was to analyze in vitro the cellular behaviour of human 
genetically determined NCL fibroblasts derived from skin biopsies of patients affected 
with NCL forms, harbouring mutations on CLN1, CLN3, CLN5, CLN6 and CLN7 genes. 
Specifically, fibroblasts cell lines were analyzed in a ‘prolonged culture paradigm’ in order 
to assess which cellular responses could be activated by NCL cells, carrying a pre-existing 
endo-lysosomal dysfunction, to cope with the aging process in vitro.   
We focused our attention principally on the evolution of the endo-lysosomal system 
during the prolonged growth; at the same time, we checked the mitochondria functionality 
and the activation of the apoptotic pathway. Both morphological and biochemical tools 
were used. 
The morphological investigation of the endo-lysosomal system revealed that the aging of 
NCL cultures was associated with a progressive accumulation of lysosomal elements 
(lysosomal bodies, autolysosomes and empty vacuoles) in different manner as compared to 
controls. Furthermore, a different behaviour in the accumulation process of dense bodies 
and single membrane vacuoles was seen between CLN1 and the other forms. The detection 
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of autophagosomes led to investigate the autophagic pathway, that was found to be 
activated in several cell lines, regardless the NCL forms and the severity of mutation. 
Moreover, the morphological alterations of the endo-lysosomal compartment occurring in 
all NCL cell lines affected the mitochondrial network and the distribution of polarized 
mitochondria as well. No evidences of apoptotic activation were seen under basal 
conditions during the prolonged growth in all the cell lines analyzed. However, the 
treatment with the apoptotic chemical inducer Staurosporine revealed a different activation 
of the caspase-3 dependent apoptosis in two CLN1 lines as compared to the other NCL 
forms and controls. These results suggested that autophagy is activated in NCL fibroblasts, 
probably as a rescue cellular program to cope with the endo-lysosomal stress, intensified 
by the prolonged growth in vitro. At the same time, mitochondria, a vital compartment for 
the cell survival, were secondary affected in this in vitro model, whereas the indirect 
evidence of involved apoptotic pathway in CLN1 only seems to be consistent with recent 
scientific reports.  
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3. INTRODUCTION 
 
LYSOSOMES AND LYSOSOMAL STORAGE DISEASES (LSD) 
Lysosomes and the endo-lysosomal system  
The endo-lysosomal compartment of the cell include different membrane organelles that 
interact together through specific targeting mechanisms and fusion processes in order to 
degrade, sort and recycle material of different origin (Vellodi, 2005; Sleat et al, 2007; 
Lubke et al, 2009). The endo-lysosomal system is made up principally of early endosomes, 
localized prevalently to the cell periphery, late endosomes, that are perinuclear and 
lysosomes. Lysosomes are ubiquitous, small, single membrane organelles marked by a low 
lumen pH that contain many hydrolytic enzymes. These enzymes are responsible for the 
capability to degrade the substrates that are carried to lysosomes throughout different 
cellular pathways. Moreover, the lysosomal membrane is composed by many structural 
proteins that accomplish different tasks, such as maintenance of low pH within lysosomes 
(as in the case of proton pump V-type H+ ATPase), fusion process and transport and 
recycling of cellular component between cytosol and lysosomal lumen. However, the 
precise functions of most part of lysosomal membrane proteins remain still unclear (Saftig 
and Klumperman, 2009).  
Lysosomal enzymes that have to be delivered to lysosomes follow specific routes among 
different cellular compartment. They are synthesized as inactive precursors in the rough 
endoplasmic reticulum (ER), modified by N-glycosylation  in the lumen and then sorted by 
vesicles budding from ER to the Golgi apparatus. Once here, the precursors are again post-
translationally modified. An important modification in the Golgi apparatus is the 
acquisition of mannose 6 phosphate (M6P) residue that is recognized by a specific receptor 
(M6Pr), allowing to sort proteins destined to lysosomes from those that have to be 
secreted. However, several proteins are correctly targeted to lysosomes without M6Pr 
pathway, probably throughout other less-known routes. Moreover, a portion of newly 
synthesized enzymes is not directly captured by M6P-receptor in the Golgi but they are 
secreted out of the cell and subsequently endocyted from neighbouring cells via M6Pr, 
localized on the plasma membrane. Finally, lysosomes are the last stage of maturation of 
lysosomal enzymes, where they become functionally active. Despite knowledge about the 
maturation pathway of hydrolytic enzymes, less it is known about the sorting and targeting 
mechanisms of lysosomal membrane protein. 
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Lysosomes and the degrading pathways of the cell: role in autophagy 
Lysosomes play an essential role in the degradative pathways of the cells (Walkley, 
2009). They receive different substrates both from outside (through endocytosis or 
phagocytosis according to the size of the material) and inside the cell (through the 
autophagic pathway).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
As regards the degradation of cellular elements, the two main degradative pathways of 
the cells are macroautophagy, also referred to autophagy, and ubiquitin-proteosome system 
(UPS; Winslow et al, 2008). UPS, through the bind of ubiquitin residues to the target 
protein, is responsible for the degradation and recycling of short-lived cytosolic and 
nuclear proteins. The ubiquitin-tagged proteins are carried to a 2000 kDa multi subunit 
complex, the proteasome, and proteolitically cleaved inside this ‘barrel-shape’ complex. 
Due to the specificity of the process and the small size of the proteasome, many proteins 
are unable to be degraded by the UPS, including oligomers and proteins in organelles. On 
the other side, autophagy is the main mechanism by which cells remove and at last degrade 
Figure 1.  
Central role of lysosomes in the degrading pathway, represented for neuronal cells. Lysosomes 
receive cargos from different elements of endo-lysosomal system, such as autophagic vacuoles and 
endosomes. Moreover, lysosomes interact with two other degradative pathways, UPS and CMA. 
Lysosomes are not simply a deadly point: many components arriving in the lysosomes can be 
delivered to other cellular compartment through ‘salvage’ pathways. EE, early endosomes; LE, late 
endosomes; LY, lysosome; AV, autophagic vacuole; SE, signalling endosome; RE, recycling 
endosome; ER, endoplasmic reticulum (from Walkley, 2009). 
 8
bulk cytoplasmic components (Levine and Kroemer, 2008; Mizushima et al, 2008 and 
2010). Autophagy contributes to maintain cellular homeostasis and carries out many 
important functions in physiological processes of the cell, such as generation of ATP and 
nutrients in starved conditions, clearance of cellular debris and damaged organelles and 
finally elimination of unfolded proteins, in association with the unfolding protein response 
(UPR) system in the so called ‘chaperone mediated autophagy’ (CMA). Lysosomes are 
key elements of the autophagic pathway, because the autophagic cargo could be degraded 
only after the fusion with lysosomes. However, lysosomes could be not simply consider as 
the final step of the degrading pathway of the cell, because they are able to recycle cellular 
components and to secret their content after fusion with the plasma membrane. 
The early step of the autophagic process is characterized by the formation of double-
membrane structures, called autophagosomes, that surround cytoplasmic components of 
the cell, including organelles such as mitochondria. In the middle and late steps, 
autophagosomes fuse with lysosomes to form autophagolysosomes (called also 
autolysosomes), in which lumen components are degraded by lysosomal hydrolases. The 
different phases of the autophagic process rely on the functions of autophagic related 
proteins (Atg), in particular the Atg12-Atg5 complex and Atg8/LC3 (microtubule 
associated protein 1 light chain 3). Atg12-Atg5 is an ubiquitin-like enzymatic complex that 
convert LC3 from a cytoplasmic isoform I to an autophagosome-associated isoform II, that 
is inserted in the double membrane during the autophagosomal formation (Genge and 
Klionsky, 2008). In particular, this complex add a phosphatidylethanolamine (PE) residue 
to the LC3 I, that increases the hydrophobicity of isoform LC3 II and generates different 
mobility patterns on SDS-page electrophoresis, allowing to distinguish the two isoforms by 
western blot analysis. Thus, the conversion of LC3 between isoform I to isoform II is 
marked by the identification of two distinct bands, at 16 kDa and 14 kDa, corresponding to 
LC3 I and LC3 II respectively. Subsequently, mature autophagosomes fuses with 
lysosomes forming the autophagolysosomes. After the fusion, the release and subsequent 
activation of hydrolytic enzymes in the lumen bring on the degradation of the inner 
membrane, leaving single membrane autophagic vacuoles with partially degraded material 
inside. So, LC3 II is partially removed from the autophagolysosomal membrane and 
returns finally to the cytosol. For these reasons, the use of electron microscopy analysis 
allows to detect both autophagosomes and later autophagic vacuoles, whereas LC3 II 
marked mainly the autophagosomes and therefore an early step of the autophagic pathway 
(Tadsemir et al, 2008; Eskelinen, 2008). Increased level of autophagosomes formation 
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could reflect an enhancement or a block of the autophagic pathway and this condition is 
thought to be related to a type of cell death (so called ‘autophagic cell death Type II’; 
Maiuri et al, 2007).  However, it is more correct to say that autophagic cell death happens 
‘with autophagy’ than ‘through autophagy’ because autophagy seems to act as a rescue 
program in order to prolong cell survival and prevent cell death in response to different 
toxic stimuli (as in the cases of protein aggregates in Huntington and Alzheimer diseases). 
Thus, in spite of its function in maintaining cellular homeostasis, an over-activation of the 
autophagic process could be detrimental for the cell survival. 
 
Lysosomal storage diseases 
The complexity of lysosome biogenesis and the large amount of lysosomal functions, 
briefly described above, imply that many alterations, occurring at different steps of these 
processes, could severely affect the homeostasis of lysosomes. Lysosomal storage diseases 
(LSD) are rare genetic metabolic disorders caused by alterations on proteins generally 
involved in lysosomal functions, leading to storage of undigested cellular material 
(Walkley, 2009). With only few exceptions, LSD are recessively inherited disorders and to 
date more than 50 different forms are known. Despite the fatal outcome, LSD patients are 
normal at birth and start showing clinical symptoms after several weeks in the most severe 
cases or commonly after a few years. Different organs are the main targets of LSD, such as 
bones, bone marrow, skeletal muscle, liver; the central nervous system (CNS) is affected in 
about two-third of LSD. Yet it is noteworthy that the systemic manifestations depend 
mainly on the distribution of the substrates in the different tissues. With regard to CNS, 
many LSD show a chronic degeneration of cortical and cerebellar neurons associated with 
an intense glial response.  
Originally, LSD were divided on the basis of the biochemical substrates that accumulate 
in the cell as a consequence of the lysosomal alteration. Nevertheless, the distinction on the 
basis of stored material is quite ambiguous, because different LSD could share the same 
storage materials or a mixture of them. More precise is the classification on the basis of the 
biological process altered in a specific condition, independently from the stored material. 
Thus, LSD could arise from deficiency in enzymatic or non enzymatic proteins, localized 
either in lysosomes or in other cellular compartments. For this reason, we could identify 
‘primary’ lysosomal disorders, in which the altered protein is a lysosomal constituent and 
‘secondary’ lysosomal disorders. In the former case, the molecular defect can affect either 
hydrolytic enzymes of lysosomes (as well as their ancillary activating protein) or structural 
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proteins of lysosomal membrane. In the latter, alteration of lysosomes function may 
originate from mutations on proteins that reside in other cellular compartments. Indeed, 
several LSD occur due to alterations in ER or Golgi resident enzymatic or structural 
proteins that could affect the synthesis, post-translational modifications, sorting or stability 
of different lysosomal proteins. For instance, mucopolysaccaridosis II and III rise from 
alterations in Golgi enzymes responsible for the M6P modification. This leads to a global 
defects on lysosome biogenesis because many new synthesized lysosomal hydrolytic 
proteins fail to be targeted to lysosomes in an appropriate manner. Another example is the 
multiple sulfatase deﬁciency (MSD) that affects the entire sulfatase family, at least seven 
members of which are lysosomal enzymes, specifically involved in the degradation of 
sulfated glycosaminoglycans, sulfolipids or other sulfated molecules. Neuronal Ceroid 
Lipofuscinoses (NCL) represent a fascinating group of LSD that share common clinical 
features in spite of biological heterogeneity as regards the localization and function of the 
proteins involved. For this reason, NCL represent a good model to investigate the 
lysosomal function and the biological alteration generating from different cellular 
compartments that lead to functional lysosomal unbalance. 
 
NEURONAL CEROID LIPOFUSCINOSES 
Neuronal ceroid lipofuscinoses (NCL) are a group of degenerative disorders of childhood 
mainly affecting CNS, and are characterized by the storage of lysosomal material with 
specific ultrastructural features, both in neuronal cells and other peripheral tissues (Jalanko 
and Braulke, 2009; Simonati et al, 2009). NCL are genetically determined and inherited as 
recessive autosomic traits (Mole et al, 2005). NCL exhibit a worldwide estimated 
frequency of 1 affected person per 12.500 live newborns; in Italy a recent survey of 
genetically determined cases over a 15 year period resulted in an incidence of 0.90/100.000 
births (unpublished observations). 
 
Historical notes 
The first description of a NCL has been commonly attributed to a Norwegian physician, 
Dr Otto Christian Stengel (Zeman et al, 1970). In 1826 he described four siblings that at 
the age of 6 began to develop blindness, progressive motor deterioration and loss of 
speech, epileptic seizures and premature death. This case report, written in Norwegian, 
remained unnoticed for a century, until other patients with visual and motor impairment 
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were studied by several clinicians (Tay Sachs, Batten, Vogt, Spielmeyer, Jansky and 
Bielschowsky). On the basis of similar clinical features and evidences of accumulation of 
lipidic material in nerve cells, these disorders were classified as ‘amaurotic family 
idiocies’. Only in the early 1960’ biochemical and ultrastructural studies on the storage 
material revealed the heterogeneous nature of this group of disorders, allowing to separate 
the conditions that store gangliosides from those that store lipopigment such as lipofuscin. 
In order to distinguish the latter group from gangliosidosies or Tay Sachs disease, Zeman 
and Dyken proposed the new term of ‘neuronal ceroid lipofuscinoses’ (Zeman and Dyken, 
1969). 
 
Clinical features and pathological findings 
NCL are a heterogeneous group of disorders that share common clinical symptoms and 
histopathological features. NCL occur mainly in childhood and are marked by retinopathy 
leading to visual impairment, gait abnormalities (due to the cerbellar involvement and 
spasticity), epileptic seizures associated with psychomotor decline and dementia. Most 
severe forms have a fatal outcome within the second decade of life.  
From a histopathological point of view, NCL are characterized by a severe cerebral and 
cerebellar atrophy due to widespread neuronal cell loss. Affected neurons at biopsy show 
storage of autofluorescent, PAS and Sudan B black positive glicolipidic inclusions that 
present characteristic ultrastructural features (granular osmiophilic deposits, GRODS; 
curvilinear bodies, CB; rectilinear profile, RP; fingerprint profile, FPP). This peculiar 
storage material is also termed cytosomes. Even if the most affected target in NCL is the 
CNS, cytosomes could be detected in other peripheral tissues, such as skin, muscle, gut and 
peripheral blood cells without evidence of dysfunction of such tissues. By the end of ‘80s 
biochemical studies on a sheep NCL model and human biopsies revealed that cytosomes 
were largely composed of protein despite of lipid. In particular, the majority of NCL forms 
contain mainly subunit c of ATP synthase (SCMAS), whereas in the infantile form the 
most abundant stored components are sphingolipid activator protein (saposins, SAP) A and 
D. 
 
NCL classification 
Historically, NCL were divided in four distinct NCL forms on the basis of the age of 
onset of the early symptoms: Infantile (INCL), Late-Infantile (LINCL), Juvenile (JNCL) 
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and Adult (ANCL) forms. A rare congenital NCL form has also been described (Siintola et 
al, 2006; Steinfield et al, 2006).  
Classically, the diagnosis of NCL is based on both the description of clinical symptoms 
and the identification of cytosomes in rectal and skin biopsies or on lymphocyte pellet. 
However, in the ’90s advances in genetic analysis allowed the discovery of gene causing 
classical infantile form CLN1 (Vesa et al, 1995) and juvenile form CLN3 (The 
International Batten Disease Consortium, 1995). Then, over the last decade, other NCL 
genes carrying many mutations were identified, expanding the spectrum of NCL genes and 
providing further elements for a more precise definition of this group of disorders.  
To date, eight NCL genes and approximately 200 mutations have been identified 
(comprehensively reported and listed in the NCL Mutation Database, 
http://www.ucl.ac.uk/ncl/). The recent classification is based prevalently on genetic 
knowledge and clinical criteria and distinguish among ten different NCL forms, from to 
CLN1 to CLN10 (table 1). Five different genes (CLN2, CLN5, CLN6, CLN7 and CLN8) 
are responsible for the Late Infantile NCL form and its variants, but it is important to note 
that different mutations in a single gene may result in different phenotypes, including 
different ages of onset. CLN4 and CLN9 genes have not been cloned so far. In addition, 
several NCL cases fail to show mutations in any of known NCL genes, so new NCL genes 
related to these ‘orphan’ forms have to be discovered yet. Orthologous NCL gene were 
also described on several animal models, such as sheep, dogs and mouse. These animal 
models mimic various NCL clinical and histopathological features, such as motor decline, 
reduced lifespan, lipofuscin inclusion and extended neuronal cell death (Jalanko and 
Braulke, 2009). Moreover, other models such as yeast cells, caenorhabditis elegans, 
drosophila melanogaster and zebrafish were genetically modified in NCL related genes 
and extensively employed in order to unravel NCL protein functions and the alterations 
associated with these mutated proteins (Cooper et al, 2006; Haines et al, 2009). 
 
NCL diagnosis 
Diagnosis of these disorders is now performed by description of clinical symptoms and 
mutational confirmation. Detection of cytosomes, an essential method in the ‘pre-genetic 
era’, is still very useful in the diagnosis because it could address to the appropriate genetic 
analysis for the determination of the precise NCL form. Moreover, biochemical enzymatic 
tests are also available for three NCL forms, specifically CLN1, CLN2 and CLN10, which 
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Table 1.   
NCL classification and related gene product. 
 
are caused by alterations in three specific hydrolytic lysosomal enzymes (Kohlschütter and 
Schulz, 2009). 
 
NCL gene products 
The characterization of NCL genes confirms that NCL are an heterogeneous group of 
disorders, despite similar clinical phenotypes. Specifically, NCL genes code for proteins 
that are localized in the lysosomes, or in other cellular compartments, such as the 
endoplasmic reticulum (ER), the Golgi apparatus and the synaptic vesicles. For this reason, 
it has been proposed to divide NCL as ‘primary’ and ‘secondary’ lysosomal disorders 
(table 1). Specifically, three forms (CLN1, CLN2 and CLN10) could be considered as 
‘primary’ lysosomal disorders because the affected proteins are hydrolytic lysosomal 
CLN1 PPT1 (Palmitoyl Protein thioesterase); Soluble enzyme: Lysosome; GROD / SAP A and D
Infantile Synaptic vesicles;
vLate Infantile Synaptosomes;
vJuvenile Axons
Adult
CLN2 TPP1 (Tripeptidyl Peptidase I); Soluble enzyme: Lysosome; CVB (RP, FPP) / SCMAS
cLate Infantile - removal of tri-peptides
CLN10 Cathepsin D; Soluble enzyme: Lysosome; GROD / SAP A and D
Congenital - hydrolisis of shingolipid, pro-saposins
vJuvenile
CLN3 CLN3 protein; Membrane protein: Lysosomes-Endosomes; FPP (RP, CVB) / SCMAS
Juvenile - arginine transport? Golgi apparatous;
- maintainance of pH? Synaptosomes;
- vesicular trafficking?
CLN4 ? ? ? GROD-like / SCMAS
Adult
CLN5 CLN5 protein; Membrane/soluble protein: Lysosome; FPP, CVB, RP / SCMAS
vLate Infantile - unknown function Axons;
CLN6
vLate Infantile CLN6 protein; Membrane protein; Endoplasmic reticulum; CVB, FPP, RP  / SCMAS
- unknown function
- dimerization ?
CLN7 MSFD8/CLN7 protein; Membrane protein: Lysosome; FPP (RP, CVB) / SCMAS
vLate Infantile - transporter
CLN8 CLN8 protein; Membrane protein: Endoplasmic reticulum; CVB, GROD / SCMAS
vLate Infantile - lipid sensor?
Northen epilepsy
CLN9 CLN9 protein; Regulatory enzyme; ? CVB, GROD / SCMAS
vJuvenile
Abbreviations:
Cytosomes & storage 
material
- removal of palmitate by hydrolisis of
thiosteric bound in S-acylated protein 
c: classical; v: variant; GROD: granular osmiophilic deposits; CVB: curvilinear bodies; FPP: fingerprint profiles; RP: rectilinear profile; SAP A and D: saposins A and D;
SCMAS: subunit c of mitochondrial ATP synthase
NCL Form Protein Protein topology & function Cellular localization
Pr
im
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y 
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m
al
 N
C
L
Se
co
nd
ar
y 
ly
so
so
m
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L
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enzymes (palmitoyl protein thioesterase PPT-1, tri-peptidyl peptidase TPP-1 and cathepsin 
D respectively). Otherwise, the other forms could be defined ‘secondary’ lysosomal 
disorders since the altered proteins are localized on different membranous cellular 
compartments (including the lysosomal membrane) and their functions are not fully 
determined yet. The comprehension of the functions of the single NCL proteins and the 
molecular cross-talk among them in a putative common metabolic pathway are the major 
challenging issues in the NCL field. 
 
CLN1 
CLN1 gene resides on chromosomes 1p32 and encodes for palmitoyl protein thioesterase 
1 (PPT1), an hydrolytic enzyme that catalyze the hydrolysis of thioesteric bond in S-
acylated proteins and removes palmitate from them (Vesa et al, 1995). The substrates of 
PPT1 are not well-characterized so far; it has been shown that PPT1 removes palmitate 
residues from H-RAS, at least in vitro (Camp et al, 1993). PPT1 polypeptide is constituted 
by 306 amino acids, with 25 amino acid N terminal signal sequence that is 
cotranslationally cleaved. It contains three different N-glycosylation sites, necessary for its 
stability, and migrates with an apparent 35/37 kDa molecular weight. The crystal structure 
of bovine PPT1, that shows 95% of homology with human PPT1, has been characterized 
and reveal an -serine hydrolase structure, typical of lipases, in according to the 
palmitate removing function previously hypothesized (Bellizzi et al, 2000). Protein 
palmitoylation or, more specifically, S-acylation is a reversible post-translational lipid 
modification, which is of relevant importance in neurons, particularly in synaptic vesicle 
turnover (Prescott et al, 2009). PPT1 shows different features in neuronal and non neuronal 
cells. Several studies show that PPT1 is localized in lysosomes, but in brain tissue and 
cultured neurons it has also been detected in the cell soma, axonal varicosities and pre-
synaptic terminals, including synaptosomes and synaptic vesicles (Verkruyse et al, 1996; 
Heinonen et al, 2000; Lehtovirta et al, 2001; Ahtiainen et al, 2003). Moreover, it has been 
demonstrated that PPT1 could homodimerize or oligomerize in vivo and that other cellular 
sorting pathways, in addition to the classical M6Pr route, could traffic CLN1p within 
neurons (Lyly et al, 2007). The precise function of PPT1 remains unclear but the lipase-
like structure and the de-palmitoylation capability suggest that in neurons PPT1 acts near 
the cell membrane and it is involved in different important processes, such as endocytosis, 
vesicular trafficking, receptors recycling and targeting, synaptic function (Goswani et al, 
2005). In particular, palmitoylation is a post-translational modification that is characterized 
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by the addiction of a carbon 16 saturated fatty acid in a reversible manner (Husseini and 
Bredt, 2002; Huang et al, 2005). This modification increases the protein hydrofobicity, 
facilitates membrane interaction with lipid bilayers and finally influences the cell sorting 
and trafficking of the modified protein. This process is very important for neuronal cell, 
because it may be involved in the correct cell sorting, axonal development, ion-channel 
clustering and synaptic function (Husseini and Bredt, 2002). In addition to the important 
functions on recycling of proteins in neurons, PPT1 seems to be related to the apoptotic 
cell death. As a matter of fact, an over-expression protects from apoptosis (Cho and 
Dawson, 2000) whereas a decreased expression enhances susceptibility to induced 
apoptosis in neuroblastoma cell line (Cho et al, 2000). Moreover, also TNF -induced 
apoptosis has been reported to be functionally altered in PPT1 deficient cell lines (Tardy et 
al, 2009). 
Mutations in CLN1 gene cause CLN1 disease and 45 different mutations have been 
described so far. The age of onset is typically around the first year of life for the classical 
infantile form, but some mutations are associated with other NCL forms, spanning from 
the late infantile to the juvenile forms (Simonati et al, 2009). Few adult cases are also been 
described (van Diggelen et al, 2001). The genetic mutational analysis of CLN1 gene is 
often associated with a reliable enzymatic test on blood sample to determine the PPT1 
activity. In same cases it is possible to correlate the clinical severity of disease with the 
residual enzymatic activity: mutations causing truncated protein or minimal residual 
activity tend to result in earlier onset and more rapid progression whereas milder 
mutations, such as missense mutations, result in later clinical onset and slower rate of 
neurodegeneration. The ultrastructural hallmark for all the CLN1 phenotypes form is the 
detection of GRODs in neuronal and peripheral tissue, including skin and rectal biopsies. 
The most abundant stored material are sphingolipid activator protein A and D (Ahtiainen et 
al, 2006). Which is the precise metabolic pathway leading to the origin of the glycolipidic 
and protein deposits remains still unknown.  
 
CLN2 
The CLN2 gene is localized on chromosome 11p15 and encodes for the tripeptidyl 
peptidase 1 (TTP1), a lysosomal hydrolytic enzyme broadly expressed in different tissues 
(Sleat et al, 1997). CLN2 protein is synthesized as an inactive precursor of 563 amino 
acids, with a 19 amino acids signal peptide co-translationally cleaved in the ER lumen, and 
then processed to mature form in the lysosome (Golabek et al, 2003). It contains 5 distinct 
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glycosylation sites necessary for the maturation and appropriate targeting of the protein 
(Wuiek et al, 2004). TPP1 is an hydrolytic enzymes that is able to remove tripeptides from 
proteins. The crystal structure has been recently characterized, allowing to unravel the 
catalytic site and the conformational changes during the maturation of the protein (Pal et 
al, 2009; Guhaniyogi et al, 2009; Walus et al, 2005). In vivo substrates of TPP1 are still 
unknown, but in vitro studies showed that subunit c of mitochondrial ATP synthase is 
processed by TPP1 (Ezaki et al, 1999). Interestingly, SCMAS, a highly hydrophobic 
subunit of ATP synthase, is the mainly protein material included in cytosome typical of 
CLN2 and other NCL forms. Other putative in vitro targets are beta amyloid peptide, 
angiotensins I and II, glucagons, cholecystokinin and neuromedin but no one of these 
substrates are detected in the storage material. 
Mutations in CLN2 gene lead to classical late infantile NCL and to date more than 50 
mutations have been described. All the mutations lead to a reduction of enzymatic activity 
and result in a clinical phenotype that show common clinical features. CLN2 patients show 
the first symptoms classically in late infancy (between 2 and 5 years); seizures and ataxia 
are the clinical hallmark, followed by progressive mental and motor decline. Visual 
impairment begins later and death occurs in the second decade. Ultrastuctural analysis of 
the cytosomes reveals the presence of curvilinear bodies that are the hallmark of CLN2 
disease; in addition, FPP are often detected. The 85% of the storage material is made up of 
SCMAS, but also SAP A and D are present in lower amount (Jalanko and Braulke, 2009; 
Palmer et al, 1992 ). 
 
CLN3 
The CLN3 gene resides on chromosome 16p1, contains 15 exons spanning 15 kb and 
encodes for a 438 amino acids polypeptide. CLN3 protein is an integral membrane protein, 
which presents six transmembrane domain, with both N- and C-termini facing to the 
cytoplasm. As for other NCL proteins, the over-expression assay indicates that CLN3 
localizes in lysosomes on non-neuronal cells, whereas on neuronal cell the protein has been 
detected in the endo-lysosomal compartment and in synaptosomes. Moreover, other 
various subcellular localizations have been described, including mitochondria, Golgi 
apparatus and late endosomes. Taking together, these finding suggest that CLN3p may 
shuttle across Golgi apparatus and plasma membrane through the endo-lysosomal pathway 
(Jalanko and Braulke, 2009).  
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The precise CLN3p function has not been characterized so far, but recent findings on 
yeast cells and mouse models shed lights on the processes in which CLN3 protein is 
involved. In particular, Saccaromyces pombe with a deletion in CLN3 homologue gene 
(btn-1) showed increased pH in vacuoles, which are the yeast organelle corresponding to 
lysosomes in mammalian cell (Gachet et al, 2005). Interestingly, it has been reported that 
lysosomal pH is affected in different NCL fibroblasts, including juvenile NCL fibroblasts, 
suggesting a role for CLN3/btn1- protein in the maintenance of lysosomal pH 
(Holopainen et al, 2001). Moreover, other putative functions of CLN3p have been 
hypothesized, including lysosomal arginine transport, membrane fusion, vesicular 
trafficking, cytoskeletal linked function, autophagy, apoptosis and proteolipid 
modifications (Jalanko and Braulke, 2009; Rusyn et al, 2008).  
Mutations in CLN3 gene give rise to the juvenile form of NCL. JNCL represents the most 
common form of NCL world-wide. More than 40 different mutations have been identified 
so far. The most frequent mutation is a large deletion of a 1.02 kb that erase exons 7 and 8 
in CLN3, producing a severe truncating protein. If this protein retain a residual activity is 
still debated. Other mutations usually lead to retention of the mutated protein in the ER 
compartment; however, some mutations, linked to a milder phenotype, seem to allow the 
mutated CLN3 protein to leave the ER (Järvelä et al, 1999; Haskell et al, 2000; Jalanko and 
Braulke, 2009). JNCL patients show the first symptoms between 5 and 10 year, in 
particular the visual impairment due to retinal degeneration is the first manifestation. 
Successively, JNCL patients develop mental deterioration, followed by epilepsy and motor 
decline. Death occurs in the third decade, or even later. Ultrastructural analysis reveals the 
presence of FPP, in association with CVB and RP in some cases, either within lysosomal 
bodies or surrounded by a single membrane vacuoles. Vacuoles are hallmark of CLN3 and 
have been detected both in neurons and peripheral tissues, such as in skin biopsies and 
lymphocytes. In particular, the detection of vacuolated lymphocytes, even on a blood 
smear, is a very useful tool in the diagnosis of CLN3 form, leading to the appropriate 
mutational analysis of the gene. The storage deposits contains mainly SCMAS. 
 
CLN4 
The CLN4 form, termed also Kufs disease, is an heterogeneous group of NCL with 
clinical manifestations in the adult age (ANCL). Two major ANCL phenotypes are known. 
The ultrastructural analysis of storage material and the cytosomes distribution are very 
important tools in the differential diagnosis with other progressive dementia of adulthood. 
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Actually, GROD-like deposits, in association with CVB and FPP, are often detected in 
neuronal cells and other tissues. However, in a few cases negative ultrastructural analysis 
of peripheral tissues makes a cerebral biopsy necessary to address to the appropriate 
diagnosis (Simonati et al, 2009). Interestingly, CLN4 is the only known NCL form in 
which an autosomic dominant trait of inheritance has been reported. At present it is not 
known how many putative genes might be responsible for this disease. 
 
CLN5 
CLN5 gene is localized on chromosome 13q21 and encodes for a 407 amino acid 
polypeptide with a predicted molecular weight of 46kDa (Savukoski et al, 1998). CLN5 
mRNA contains four different initiation methionines sites and an in vitro translation assay 
demonstrated the production of 4 different polypeptides with apparent molecular weight 
raising from 37 to 47 kDa. CLN5 function and its topology are still unclear. Mouse CLN5 
is reported to be a soluble protein (Holmberg et al, 2004); moreover, human CLN5 
contains mannose-6-phosphate residues indicating the existence of soluble CLN5 variants 
(Isosomppi et al, 2002; Sleat et al, 2006; Schmiedt et al, 2010). The over-expression of 
CLN5 indicated that CLN5p is localized in the lysosomal compartment, but in neurons, in 
the same way as CLN1p and CLN3p, it was detected also in the axons. 
Immunoprecipitation and in vitro binding assay suggests that CLN5p interacts with two 
other NCL protein, CLN2 and CLN3, suggesting for the first time the possible existence of 
a interaction among different NCL proteins (Vesa et al, 2002; Lyly et al, 2009). Recently, 
evidence has been provided of disease occurrence associated with CLN5p retention in the 
ER (Lebrun et al, 2009). 
Alterations in CLN5 cause a variant of Late Infantile NCL (Bessa et al, 2006; Cannelli et 
al, 2007; Savukoski et al, 1998). The first symptoms start classically between the age 2 and 
6 years and are principally the mental decline followed by blindness, ataxia and epileptic 
crisis. The cytosomes that mark CLN5 form are CVB in association with FPP, but in same 
case also variant of rectilinear profile are observed. The major storage component is 
SCMAS. 
 
CLN6 
The CLN6 gene lies on chromosome 15q22-23 and encodes for a 311 amino acid 
polypeptide formed by seven predicted transmembrane domains, with a cytosolic N-
terminus and a lumen C-terminus. This protein resides on endoplasmic reticulum and in 
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neuronal cells is detected along neuronal extension in subdomains of a tubular ER network 
(Jalanko and Braulke, 2009). The function of CLN6 protein and the mechanism by which it 
could influence the accumulation of lysosomal material are unclear so far. In the same way 
as other NCL forms, CLN6 fibroblasts show increased lysosomal pH (Holopainen et al, 
2001) and an altered degradation of endocytosed arylsulfatase A, probably due to an 
intracellular distribution of both M6Pr and endocytic adaptor proteins (Heine et al, 2004). 
However, neither sorting of newly synthesized cathepsin D, nor the activity of several 
lysosomal enzymes (CtsD, -hexosaminidase and arylsulfatase A) were affected in CLN6 
fibroblasts (Heine et al, 2004). Moreover, single membrane vacuoles have been detected 
on human biopsies, suggesting that the alteration of CLN6p could influence and trigger an 
autophagic response in vivo (Cannelli et al, 2009). It has been proposed that CLN6p is able 
to form dimers, so the effects of mutations could affect the correct localization or the 
capability of homodimerization.  
Mutations in CLN6 cause a variant late infantile NCL form. Clear-cut genotype-
phenotype is not possible, because most of mutations show similar disease clinical course 
(Simonati et al, 2009). It could be speculated that milder phenotype depend on the residual 
capability of the CLN6 protein to dimerize. However, both intra and inter familial 
variability have been reported, supporting the idea of additional genetic or epigenetic 
determinants are important in NCL manifestations. Electron microscopy analysis on 
biopsies and cell show the accumulation of RP and FPP cytosomes, which contain 
prevalently subunit c of mitochondrial ATP synthase.  
 
CLN7 
The CLN7 gene has been identified recently, in 2004, by genome-wide scanning and is 
located on chromosome 4q28.1-q.28.8. CLN7 encodes for a 518 amino acids polypeptide 
with 12 putative transmembrane domains. As suggested by the predicted molecular 
structure, CLN7 is a membrane protein and belongs to the large major facilitator 
superfamily (MSF) transporting specific classes of substrates, such as sugars, drugs, 
inorganic and organic cations and various metabolites (Siintola et al, 2007). The specific 
CLN7 substrate has not been characterized so far. Overexpression of protein indicates that 
CLN7 resides on the lysosomal membrane. 
Mutations in CLN7 gene result in a typical variant late infantile form, starting usually 
with epileptic seizures and cognitive decline. Progressive motor and mental decline 
associated with myoclonus and visual impairment lead to cell death in the early second 
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decade of life (Aiello et al, 2009). The storage material closely resembles the cytosomes of 
other vLINCL forms and made up of a mixture of FPP and RP, but CVB are also detected. 
Because of similar features within the heterogeneous group of vLINCL forms, the genetic 
investigation is necessary for a correct diagnosis, supporting the clinical and ultrastructural 
investigations. 
 
CLN8 
The CLN8 gene lies on chromosome 8p23 and encodes a non-glycosylated 33kDa 
membrane protein of 286 amino acids. The CLN8 protein contains an ER-retrieval signal 
(the di-lysine motif KKRP) and it has been suggested that CLN8 protein shuttle between 
ER and ER-Golgi intermediate complex (ERGIC) (Lonka et al, 2000; Lonka et al, 2004). 
The precise structural conformation has not been characterized so far, but the CLN8 
contains probably 5 transmembrane domains. The function is unknown, but using 
computational analysis, it has been shown that it belongs to the TRAM-Lag1p-CLN8 
(TLC) molecular family proteins involving in biosynthesis, metabolism, transport and 
sensing of lipids (Winter et al, 2002;  Riebeling et al, 2003). Mass spectrometry analysis of 
brain samples of EPMR patients demonstrated changes in the molecular composition of 
several phospho- and sphingolipid molecules which may lead to altered membrane 
properties and membrane proteins functions (Hermansson et al, 2005). 
Mutations in CLN8 cause childhood-onset NCL, which has remarkable phenotypic 
differences according to the underlying mutation. One Finnish phenotype, characterized by 
early juvenile onset and slowly progressive course, with epilepsy and cognitive 
deterioration (Progressive Epilepsy with Mental Retardation, EPMR), is associated with 
one homozygous missense mutation in the CLN8 gene (Ranta et al, 1999). Different 
mutations in CLN8 (presumably leading to severe loss-of-function of the gene) were 
detected in patients from different ethnic backgrounds and affected with a more severe 
variant late infantile onset (vLINCL) phenotype with early onset myoclonus and visual 
failure, partially overlapping with classical late-infantile and juvenile forms of NCL (Ranta 
et al, 2004; Cannelli et al, 2006, Zelnik et al, 2007).  
Ultrastructural analysis of CLN8 biopsies show a mixture of CVB, FPP and, less 
frequently, GROD-like storage in skin, muscle biopsies and lymphocyte, with SCMAS as 
the main stored material.  
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CLN9 
CLN9 form is a variant LINCL form but the affected gene has not been characterized so 
far. Only four patients have been reported, resembling clinical symptoms similar to 
juvenile or CLN3 patients. Fibroblasts from these patients show several abnormalities: they 
are sensitive to apoptosis, they grow rapidly and manifest cell adhesion defect. Moreover, 
CLN9 protein could be involved in the regulation of dihydroceramide synthase, because 
fibroblasts show reduced levels of ceramide, dihydroceramide and sphingomyelin (Schultz 
et al, 2004; Schultz et al, 2006). 
 
CLN10 
The CLN10 gene lies on chromosome 11p15.5 and encodes for cathepsin D (CTSD or 
catD), the major lysosomal aspartic protease. CTSD is synthetized as an inactive 
preproenzyme (53 kDa), translocated to the ER compartment and modified post-
translationally by glycosylation in an intermediate proenzyme form of 47 kDa. Finally, this 
proenzyme is sorted to lysosomal compartment, where it becomes functionally active by 
cleavage into two chain of 34 and 14 kDa that remain associated together by hydrophobic 
interaction. The CTSD substrates are not well characterized in vivo so far, although several 
studies suggest that CTSD is able to catalyze the hydrolysis of certain shingolipids and 
pro-saposins (Benes et al, 2008). Moreover, CTSD is involved in many biological 
processes, including cancer progression, antigen presentation, regulation of plasma HDL-C 
levels and caspase-independent apoptosis (Johansson et al, 2003; Zaidi et al, 2008). 
Mutations in CLN10  lead to a congenital NCL, the most severe NCL form with seizures 
and respiratory insufficiency at birth and early fatal outcome (Siintola et al, 2006; 
Steinfield et al, 2006). Residual activity of the enzyme is nearly absent in the infantile 
form, whereas relativly high residual activity in the rare juvenile phenotype (Steinfeld et al, 
2006).  The main stored material is SAP D but not SCMAS, resembling similar storage of 
infantile NCL. Sheeps, dogs and mouse with mutations in CLN10 resemble the severity of 
NCL phenotype observed in humans beings and are useful animal model for the studies of 
these disorders. 
 
CLNx or orphan forms 
In spite of the recent advances in NCL genetic knowledge in the last decade, 10-15% of 
NCL patients do not show mutations in the eight known NCL gene. The existence of these 
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‘CLNx’ or ‘orphan’ NCL cases indicates that other NCL genes have to be discovered yet 
(Jalanko and Braulke, 2009).  
Several animal model with mutations in different endo-lysosomal proteins, such as 
channel chloride family (ClC) members or cathepsin proteins (specifically, cathepsin B, L 
and F), resemble the clinical and histopathological features of NCL disease, indicating 
possible candidate genes that could be linked to the human orphan forms.  
 
PATHOLOGICAL MECHANISMS AND CELLULAR RESPONSES IN NCL AND 
LSD 
The molecular mechanisms underlying cell pathology in LSD and particularly in NCL 
have not been fully elucidated yet. The storage of undigested substrates does not explain 
per se the various negative effects affecting the survival of the cells, and of neurons in 
particular. Different putative mechanisms have been hypothesized, that could affect the 
lysosomal compartment either directly or indirectly. Specifically, a primary effect of the 
lysosomal dysfunction is the formation of the storage. The presence of indigested material 
may engulf and induce topological distortion of the cell or could be per se a toxic factor. 
Then, any impairment of the lysosomal molecular degrading pathway could trigger an 
autophagic response in order to eliminate the storage material and to ameliorate the 
lysosomal stress. Moreover, lysosomal impairment could lead to secondary events that 
affect different compartments of the cell, such as ER, mitochondria and plasma membrane. 
Eventually, all these events together may exert negative effects on cell viability and affect 
cell survival, triggering the cell death process through several mechanisms, including 
apoptosis. 
Many different animal models have been used in order to unravel the mechanism 
underlying cell pathology in NCL and LSD. Furthermore, together with animal models, 
fibroblasts have been extensively used in the study of these disorders. It is important to say 
that fibroblasts are cells deeply different from neurons; in particular, they are more 
resistant and less vulnerable to cell death and thus they might generate bias in the study of 
pathogenetic mechanisms. However, they show several important advantages; for instance, 
they are simply available from patients and can be cultured in controlled conditions. 
Moreover, they can provide many information about the cross-talk among different cellular 
compartment and the effects due to lysosomal dysfunction, both in basal and stressful 
conditions. In addition, NCL fibroblasts store in the cytoplasm the same biochemical and 
ultrastructural material of the neuronal cells. Finally, fibroblasts represent a rapid model on 
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which test hypothetical ‘therapeutic’ strategies, in order to see if these treatments can 
rescue some cellular functions, such as in the case of chemical chaperons employed to 
alleviate ER stress (Wei et al, 2008; Dawson et al, 2010 ). So the use of fibroblasts is very 
useful to analyze the different cellular mechanisms and to make up a putative 
‘pathogenetic model’ that can be translated into neuronal biology. 
 
Storage and topological distortion 
The progressive accumulation of undegraded stored material causes a ‘steric’ engulfment 
of the cytoplasm of the cells, overwhelming the cell volume and perturbing indirectly the 
organization of other cellular compartments. In neurons, different morphological changes 
have been related to lysosomal diseases since early studies. For example, the formations of 
abnormal structures in axons, such as ectopic dendritogenesis and ‘spheroid’, have been 
described in different LSD (Vellodi, 2005; Walkey, 2009). These phenomena are 
respectively enlargements of axon hillock and aberrant swelling of the axons, that seem to 
be strictly connected to both primary or secondary gangliosides accumulation. However, 
the scenario is more complex since different neurons could be differently affected by these 
events. For examples, ectopic dendritogenesis interest usually a subset of cortical 
pyramidal neurons and GABAergic neurons, whereas Purkinje cells appear to be more 
vulnerable to spheroid formations (Walkley, 2009; Vellodi, 2005). 
 
Storage and involvement of cell organelles 
A lysosomal deficiency could secondarily affect other cellular compartments. For 
instance, ER has been reported to be involved in many LSD (Wei et al, 2008). Several 
proteins implicated in the unfolding protein response (UPR) exhibited high level of 
expression both on NCL and non NCL diseases and the use of chemical chaperones seems 
to alleviate the ER stress. In addition, also Ca2+ homeostasis appear to be altered in 
different LSD, probably as a consequence of alteration in the ER membrane composition 
that affect the capability of this cellular compartment to control the Ca2+ concentration 
(Walkley, 2009). 
Moreover, several studies suggest that the mitochondrial compartment could be 
secondarily involved in different LSD. Accumulation of dysfunctional mitochondria has 
been reported in a multiple sulfatase deficiency (MSD) mouse model, both in neuronal 
cortex and in embryonic fibroblasts (MEF) (Settembre et al, 2008). Moreover, several 
studies on fibroblasts derived from mucolipidosis type IV (MLP IV) patients and on 
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astrocytes from a GM1 mouse model demonstrated that mitochondria exhibited both 
morphological and functional abnormalities, such as decreased membrane potential and 
reduced Ca2+ buffering capability (Vergarajauregui  et al, 2008; Jennings et al, 2006; 
Takamura et al, 2008). Furthermore, mitochondrial involvement has been also investigated 
in NCL. Visual impairment is common clinical manifestation in NCL and also in other 
LSD. It is noteworthy that neurons of layer IV of visual cortex, highly dependent on 
oxidative metabolism, are particularly vulnerable to cell death. Moreover, it is known that 
the main storage material detected in cytosomes is the subunit c of ATP synthase, except 
for CLN1 and CLN10. Mitochondria showed morphological alterations (such as cristae 
abnormalities) in different human and ovine NCL fibroblasts (Jolly et al, 2002). In 
addition, the complex II and IV of respiratory chain and the ATP synthase activity have 
been reported to be compromised both in human and animal NCL fibroblasts, but in 
different manner according the different NCL forms (Das et al, 1999). These findings 
imply the question whether an ‘energetic imbalance’ could be involved in NCL pathology. 
However, it is still matter of investigations whether the mitochondrial involvement might 
reflect a secondary energetic dysfunction related to lysosomal impairment, and therefore 
have relevant implications in NCL pathogenesis. 
 
Storage and unbalance of degrading pathways: role of autophagy 
As outlined before, lysosomes are key-organelles involved in many different degrading 
and recycling pathways of the cells. So, alterations in lysosomal function affect not only 
the degradation of particular substrates but also the recycling of different cellular 
components. Thus, for instance, the dysfunction in the digestion and recycling of different 
lipids and glycoproteins could lead to perturbation of lipid rafts, specific membrane 
regions implicated in many important process of the cell, such as signalling transduction 
(Walkley and Vanier, 2009). As regards neurons, it has been demonstrated that impairment 
on endo-lysosomal system affect vital pathways for neuronal function, such as AMPA 
receptor recycling and growth factors uptake (Walkley and Vanier, 2009; Walkley, 2009).  
On the other side, also the presence of stored material could represent per se a toxic 
stimulus that cell tries to erase throughout autophagic pathway. Several LSD mouse 
models, such as mucopolysaccharidoses type IIIa (MLP IIIa) and MSD mice (Settembre et 
al, 2008), have demonstrated that an autophagic impairment, due to a lysosomal 
deficiency, could lead to the accumulation of indigested material, polyubiquitinated 
proteins, aberrant mitochondria and finally to neurodegeneration. With regard to NCL, 
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CLN3 deficient mice show storage of immature autophagic vacuoles and an increase of 
LC3 II in brain samples, suggesting a dysfunction of autophagic process (Cao et al, 2006). 
However, treatment in vitro with rapamycin, an inducer of autophagy, fail to increase cell 
survival of cerebellar cultures, whereas treatment with 3-methyladenine (3-MA), a blocker 
of autophagy, induce much more cell loss as compared to control. This result indicates that 
autophagy acts probably as a pro-survival pathway in CLN3-deficient mouse and the block 
of this process could increase the cell death. Moreover, also cathepsin-deficient mice 
(particularly, knock out for cathepsin D and double knock out for cathepsin B and L) 
exhibit increased levels of LC3 II marker and storage of double membrane vacuoles in 
both perikarya and axons of neuronal cell (Koike et al, 2005). In addition, increased LC3 II 
level are also detected not only in the brain, but also in liver and the heart, suggesting that 
the autophagic impairment is a condition common to different organs. Evidences of 
autophagic implications have also been suggested on human samples, such as the 
cytoplasmatic vacuolization detected on peripheral tissues (as well as neurons) of CLN3 
patients, and the recent demonstration of large single membrane vacuoles also on CLN6 
human biopsies (Cannelli et al, 2009). To date, it is not clear if autophagy represents just a 
rescue pathway or may be a negative mechanism for cell survival. 
 
Storage and cell death 
The relationship between lysosomal dysfunction and cell death is far to be clearly 
understood. As mentioned above, many different pathological events could arise in the cell 
and probably the single alteration is not per se a deadly trigger. Interestingly, two-thirds of 
LSD, including NCL, are marked by an extensive neuronal cell loss. The putative cellular 
mechanisms underlying this process are undoubtedly fascinating, but poorly characterized 
so far. The neuronal ‘deadly stimulus’ seems to be a ‘chronic’ stimulus, because LSD 
patients are normal at birth and neurons apparently survive for years until the onset of the 
early clinical symptoms.  So it is likely that neuron degenerate in a progressive but not 
acutely manner, even though several clinical events, such as seizures in NCL, speed up this 
deadly process.  
Many different experimental models have been employed so far in order to understand 
which mechanisms outline the extensive and selective neurodegeneration occurring in 
NCL but this matter is still controversial and debated. Several mouse model and few 
human studies suggest a causative role of apoptosis in NCL pathogenesis. 
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Apoptosis, term coined  by Kern in 1972 (Kerr et al, 1972) to indicate a programmed cell 
death (in the same way as the "dropping off" of leaves from trees), is marked by specific 
morphological and biochemical features (Kroemer et al, 2009). It is noteworthy that 
apoptosis could be associated with or without caspases activation (so called caspase-
dependent or independent apoptosis) and that several routes starting from different cellular 
organelles (such as ER, plasmatic membrane, mitochondria or lysosomes) could elicit 
apoptotic cell death (Ferri and Kroemer, 2001). Since different cellular compartments 
might be primary and secondarily involved in NCL and LSD, apoptotic pathway could be 
triggered in these disorders.  
As regards NCL, it has been showed that in ppt1 -/- mouse the activation of UPR system 
could lead to the apoptotic cell death through the ER-resident caspase-12 and the effector 
caspase-3 (Zhang et al 2006; Kim et al, 2006). Moreover, in the same mouse model the 
mitochondrial compartment could contribute to neurodegeneration by caspase-9 and 
oxidative stress (Kim et al, 2006). In addition to these evidences on mouse model, human 
NCL fibroblasts show higher level of cell death induced by brefeldin A, a chemical inducer 
of ER stress, and the use of chemical chaperones is able to reduce the cell death in this in 
vitro model (Wei et al, 2008). Furthermore, in neuroblastoma cell lines, PPT1 
overexpression seem to protect from apoptosis induction (Cho and Dawson, 2000), 
whereas the inhibition of PPT1 transcription, by using antisense oligonucleotides 
treatment, increases the apoptotic cell death (Cho et al, 2000).  
Notwithstanding these evidences of an apoptotic involvement in genetically different 
NCL forms, several studies suggest that other mechanisms leading to cell death have to be 
taken into account to explain NCL-related neurodegeneration. In particular, PPT1 and 
TPP1 deficient fibroblasts show decreased sensitization to TNF alpha-induced apoptosis, 
whereas CLN3 and CLN5 deficient fibroblasts do not exhibit a similar behaviour (Tardy et 
al, 2009, Autefage et al, 2009). Only the enzymatic correction through PPT1 gene 
transfection is able to restore the susceptibility to TNF apoptotic induction. Moreover, 
double knock out mice, which harbour mutations in a NCL and apoptosis-related genes at 
the same time, have demonstrated that neurodegeneration is still present, even though the 
apoptotic pathway lacks important factors, such as BAX (Shacka and Roth, 2007; Shacka 
et al, 2007). Moreover, over-expression of Bcl-2 or knock out of p53 fail to modify the 
lifespan of CLN2 -/- mouse model, suggesting that the apoptotic pathway, depending at 
least from Bcl-2 and p53, is not directly involved in the disease progression (Kima et al, 
 27
2009). Taking together, these findings suggest that apoptosis is not the only mechanism 
that might explain the cell death in NCL.  
 
Probably, other cellular responses, such as an increased autophagic response, might be 
also deleterious for cell survival and trigger the cell death. Impaired feed-back mechanisms 
which should regulate the physiological, rescue process of autophagy, for instance, might 
lead to extensive cytoplasmic vacuolization, which deadly impairs cytoplasmic activities, 
leading eventually cells to die (by autophagic cell death type II).  
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4. AIMS OF THE DOCTORATE PROJECT 
NCL are a heterogeneous group of neurodegenerative disorders of childhood, classically 
considered as “lysosomal disorders”. They are caused by mutations on genes codifying for 
proteins that resides on different cellular compartments, including lysosomes. NCL are 
often accounted as precocious ‘aging’ diseases due to the premature and progressive 
accumulation of lipofuscin and indigested material in neuronal tissue, leading to 
progressive cognitive decline and premature death. To date it is still not clear whether the 
storage material could be per se deleterious for the survival of neurons or may trigger 
unbalanced cellular responses (such as autophagy and apoptosis) that eventually lead to 
cell death. 
The aim of my doctorate project was to study in vitro the cellular behaviours of human 
NCL fibroblasts in order to possibly recognize any pathogenetic mechanisms that could be 
involved in some NCL forms. Specifically, we employed genetically determined human 
fibroblasts cell lines belonging to different NCL forms, with ‘primary’ (CLN1) and 
‘secondary’ (CLN3, CLN5, CLN6 and CLN7) lysosomal involvement. 
Fibroblasts were analyzed in a ‘prolonged culture paradigm’ (under basal conditions and 
following specific stresses) in order to assess whether the cellular aging could exacerbate 
the pre-existing endo-lysosomal dysfunction and influence the cellular survival. 
In particular, we studied the process of lysosomal bodies accumulation and the  
mechanisms by which cell try to cope with the endo-lysosomal stress, caused by both 
genetic alteration and the long-lasting growth. Likewise, we examined whether the endo-
lysosomal system could influence the spatial topology and the function of mitochondria, a 
cellular compartment essential for cell viability. Finally, we tried to understand whether the 
endo-lysosomal stress could induce cell death, focusing mainly on the caspase dependent 
apoptotic pathway.  
Therefore, the main topic was the study of the endo-lysosomal system and the 
morphological changes that affect this compartment during the long-lasting growth. For 
this purpose, we employed three different approaches: in vivo visualization of the acidic 
compartment using Lysotracker probe, immunofluorescence assay against Lamp2 (a 
lysosomal membrane protein) and the electron microscopy analysis. Taken together, these 
methodologies allowed us to follow up the distribution of acidic structures in the cells, to 
detect lysosomal-derived vesicles and finally to characterize their ultrastructural features. 
At the same time, we investigated the autophagic process by immunoblotting and 
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immunofluorescence analyses of two main biochemical markers, the Atg12-Atg5 complex 
and LC3 II, with the support of the ultrastructural analysis. 
Moreover, we studied the involvement of mitochondrial compartment in NCL, focusing 
on the spatial relationship between mitochondria and endo-lysosomal system and on the 
functional alteration of both polarization state of mitochondrial membrane and respiratory 
chain. Finally, we put our attention on the apoptotic process, by investigating two late steps 
of the caspase-dependent apoptotic pathway, cleavage of caspase-3 and nuclear 
fragmentation, both under basal condition and following chemical induction with 
Staurosporine. 
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5. MATERIALS AND METHODS 
 
Human fibroblast cultures 
Primary fibroblasts cultures were established from skin biopsy of healthy donors and 
NCL patients. Human fibroblasts were cultured in Dulbecco’s Modified Essential Medium 
with high Glucose (DMEM/HIGH Glucose, EuroClone) supplemented with 10% foetal 
bovine serum, penicillin (50 IU/ml), streptomycin (50 µg/ml) and amphotericin B (250 
µg/ml) (all purchased from EuroClone). Cells were incubated at 37°C in a humidified air 
with 5% CO2. The medium was changed twice a week. At confluence, cells were detached 
from the flasks with trypsin/EDTA (Sigma-Aldrich) and subcultured at the same density 
for all the cell lines. 
In table 2 a list of NCL fibroblast cell lines employed in this study is shown. Four 
fibroblast lines established from healthy children donors were used as normal controls. 
NCL and control fibroblasts were analyzed at different stages of culture in a long lasting 
paradigm. In particular, considering the isolation of fibroblasts from biopsy as the first 
passage, the experimental evaluations were set at three different culture points, the 7th, 15th 
and finally 20th passages, corresponding to “early” and “late” stages of culture 
respectively.  
For fluorescence and light microscopy analysis, at the established passages, cells were 
seeded on round glass coverslips in a 24-well plates (2000 cell per well) and cultured in 
complete medium for 48 or 72 hours until the day of experiment. 
 
Visualization of mitochondrial and lysosomal compartments by vital fluorescent dyes 
We employed two different fluorescent probe, Mitotracker and Lysotracker (Molecular 
Probes) with the aim to study mitochondrial and lysosomal compartments respectively. 
Specifically, NCL and control fibroblasts, grown on coverslips, were exposed to the 
specific fluorescent dyes (100 µM Mitotracker Red or Green, 50 nM Lysotracker DND 99) 
for 30 minutes, at 37°C 5% CO2, then rinsed in PBS and observed immediately under 
Axiolab microscope (Zeiss) for incident-light fluorescence, equipped with HBO 50 
mercury vapour short-arc lamp. Nuclei were counterstained with 2 µM Hoechst 44432 
(Molecular Probes). Moreover, to analyze the spatial relationship between mitochondrial 
network and lysosomal compartment, cells were contemporarily exposed to 100 µM 
Mitotracker Green and 50 nM Lysotracker DND 99 (Molecular Probes) at the same 
conditions described previously. Images were acquired by an AxioCam equipment using 
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AxioVision 4.3 software (Carl Zeiss). The image acquisition settings were established and 
maintained identical in all the experiments. Moreover, in order to investigate the alteration 
of the mitochondrial reticulum linked to lysosomal engulfment, we performed a semi-
quantitative analysis, determining the percentage of cells that showed a fragmented or 
distorted reticulum after Mitotracker staining. Cells were arbitrarily divided into two 
groups, cells with normal and filamentous mitochondrial network and cells with 
fragmented and discontinuous reticulum. The percentage of cells belonging to each group 
was determined and compared to controls. 
 
Mitochondrial membrane potential (Δm) 
To investigate the state of polarization of mitochondrial membrane (Δm), fibroblasts 
were exposed to JC-1 (5,5’,6,6’-tetrachloro1,1’,3,3’-tetraethylbenzimidazolyl 
carbocyanine, Molecular Probes) for 30 minutes at 37°C, 5% CO2, at the final 
concentration of 10 µg/ml in a specific medium with high K+ concentration (137 mM KCl, 
Cell Line Clinical form NCL Gene Nucleotide alteration Mutation Predicted effect on protein
CLN1 -1 vINCL CLN1 c.541G>T Missense p.Val181Leu
c.124+1214 3.6 kb deletion Multiple exon skipping
CLN1 -2 vLINCL CLN1 c.665T>C Missense p.Leu222Pro
CLN1 -3 cLINCL CLN1 c.A169-170insA 1 bp insertion Framshit after k56
CLN1 -4 vLINCL CLN1 c.125-15T>G Splice site Aberrant splicing
CLN3 -1 JNCL CLN3 c.462-677del 1.02 Kb deletion Frameshift after C153
CLN3 -2 JNCL CLN3 c.462-677del 1.02 Kb deletion Frameshift after C153
c.222+2T>G Splice site Aberrant splicing
CLN5 vLINCL CLN5 c.772T>G Missense p.Tyr258Asp
CLN6 -1 vLINCL CLN6 c395delCT 2-bp deletion p.Asp132CysfsX17
c.715delTTCG Nonsense p.F238fs
CLN6 -2 vLINCL CLN6 c.406C>T Missense p.Arg136Cys
c.426C>G Nonsense p.Tyr142X
CLN6 -3 vLINCL CLN6 c.316insC 1-bp insertion p.Arg106ProfsX26
CLN7 vLINCL CLN7 c.154G>A Missense p.Gly52Arg
c.863+3insT 1-bp insertion Altered splicing
Table 2.   
NCL fibroblasts cell lines and related mutations employed in this study. 
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3.6 mM NaCl, 0.5 mM MgCl2, 1.8 mM CaCl2, 4 mM HEPES, pH 7.2, with 1 mg/ml D-
gluscose). The sample was analyzed by Axiolab microscope and images were acquired in 
the same way as for Lysotracker and Mitotracker. JC1 localizes to mitochondrial 
membrane and changes its molecular conformation according to the Δm. In particular, for 
high Δm, JC-1 forms dimeris and displays red fluorescence; on the other side, when Δm 
is impaired, JC-1 is present as monomer, emits green fluorescence and could be released in 
the cytoplasm.  
 
Immunofluorescence assay 
Fibroblasts, grown on coverslips, were fixed in Methanol at -20°C for 10 minutes or 
alternatively in Methanol: Acetone 1:1 for 10 minutes at RT. After two washing in PBS, 
cells were blocked with 10% Normal Goat Serum (Dako) with the addition of 1% BSA 
(Sigma-Aldrich) and then incubated with primary antibodies over night at 4°C. Anti-
Mouse and Anti-Rabbit Alexa Fluor 488 and 594 (Molecular Probes) were used as 
secondary antibodies for 1 hour RT and the nuclei were counterstained with 4’,6-
diamidino-2-phenylindole dihydrochloride (DAPI, Sigma-Aldrich). Primary antibodies 
used in this study for immunofluorescence were monoclonal anti-Lamp2 (H4B4 clone; 
Abcam), polyclonal anti-LC3B (direct against amino-terminus region of the protein; Cell 
Signalling Technology) and polyclonal anti-cleaved caspase-3 (able to recognize amino-
terminal residues of the cleaved form but not the full length protein; Cell Signalling 
Technology).  
 
Electron microscopy  
Lysosomal compartment and mitochondria were examined by transmission electron 
microscopy (TEM). Briefly, fibroblasts at confluence in a T75 flask were collected by 
trypsinization, and centrifuged at 150 g, washed with HBSS (EuroClone) and finally in 
phosphate buffer. Cells were then fixed with 1.25% glutaraldheide and 0.5% 
paraformaldeide in phosphate buffer for 1 hour  at 4°C and post-fixed in osmium tetraoxide 
(OsO4) for 2 hours at 4°C. Cellular pellet was subsequently dehydrated by increasing 
concentrations of acetone and included in Spurr resin.  
For lysosomal compartment examination, at least two hundred of control and NCL 
fibroblasts were observed and checked for the presence of vacuoles or lysosomal bodies. 
For every single cell, a score was assigned, referring to the subjective evaluation (by two 
independent observers) of vacuoles and lysosomal bodies per cell. 
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For mitochondrial density analysis, at least 10 images of nucleated cells were acquired at 
3000X magnification. The EM photographs were acquired by a scanner at 600 dpi 
resolution and then analyzed by AxioVision 4.3 software. Mitochondria were counted 
within a total cellular area of roughly 300 µm2. We considered as mitochondria only those 
organelle that showed a clear double membrane with a unambiguous matrix and cristae 
inside.  
 
Western blot analysis 
Fibroblasts were collected from a T75 at confluence, washing twice with PBS and then 
resuspended with RIPA Buffer (150 mM NaCl, 50 mM Tris-HCl, 6 mM EDTA, 1% NP-
40, 1% SDS, 0.5% Deoxycolic acid, pH 8.0) containing protease inhibitors (Roche 
Diagnostics). After 2 hours of homogenization at 4°C, homogenates were centrifuged at 
3200 g to discard cellular debris and then the supernatant was collected and stored at -
80°C.  Protein content were determined by Bradford Assay (Sigma-Aldrich). For western 
blot analysis, twenty micrograms of total protein lysates were diluted in Laemli buffer, 
boiled at 90°C for 5 minutes and then resolved by electrophoresis in SDS-polyacrylamide 
gels under denaturing conditions. Proteins were then electrontransferred to nitrocellulose 
membrane (Bio-Rad). The membranes were blocked with TBS/0.1% Tween20 containing 
10% non-fat dry milk (Bio-Rad) and then subjected to immunoblot analysis. Primary 
antibodies were incubated over night at 4°C in TBS/0.1% Tween20 with 5% non-fat dry 
milk. The secondary antibodies, anti-Mouse IgG HRP or anti-Rabbit IgG HRP (Amersham 
GE Healthcare), were added for 1 hour at RT in the same buffer of primary antibodies. 
Chemiluminescent detection was performed with ECL Plus (Amersham GE Healthcare) 
according to manufacturer’s instructions. Quantitative blot analysis was performed by 
ImageJ software (NIH). Primary antibodies used for western blotting analysis were the 
anti-LC3 antibody previously described, the polyclonal anti-Atg12 (that recognizes a 
peptide near the amino terminus and allows the detection of the Atg12-Atg5 complex, 
corresponding to a 53 kDa band; Cell Signaling Technology) and polyclonal anti-VDAC 
(direct against amino terminus of the human VDAC-1; Cell Signalling Techonology) 
antibodies, and the monoclonal anti-COX IV (clone 20E8C12; Mitosciences) antibody. 
Polyclonal anti-Actin (that probes a N-terminal conserved region of the protein; Sigma-
Aldrich) and monoclonal anti-α tubulin (that recognizes a N-terminal domain; Invitrogen) 
antibodies were employed as quantitative loading control. 
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Biochemical assay respiratory chain 
Enzymatic activity of respiratory chain was evaluated biochemically. Fibroblasts from 1 
or 2 T75 at confluence were washed and collected in NaCl-Tris Buffer (140 mM NaCl, 35 
mM Tris/HCl, pH 7.4), then cells were resuspended in 300 µl of homogenization buffer 
(250 mM sucrose, 10 mM Tris/HCl and 2 mM EDTA, pH 7.4) and  sonicated twice at 40% 
power for 5 seconds. Finally, the lysate was diluted 1:2 with other 300 µl of 
homogenization buffer and Triton X100 (Sigma-Aldrich) was added at final concentration 
of 0,01%. Samples were incubated on ice for 30 minutes and then the activites of the 
mitochondrial enzymes Cytochrome c Oxidase (COX), NADH Cyt, Succinate 
Dehydrogenase (SDH), Succinate Cytochrome c Reductase (SCR) and NADH 
Dehydrogenase (NADH DH) were evaluated following incubation at 37° C for 5 minutes, 
as previously described (DiMauro et al, 1987). Enzymatic activity was given as 
nmol/min/mg protein and corrected for the Citrate Synthase (CS) activity that represents an 
index of the ‘mitochondrial mass’.  
 
Apoptosis evaluation 
To assay apoptotic cell death in control and NCL fibroblasts, nuclei morphology and 
caspase-3 activation were analyzed. In particular, nuclei with apoptotic morphology were 
evaluated by DAPI fluorescence, while cleavage of caspase-3 was assessed by both 
immunofluorescence and western blot analysis. Moreover, in order to induce apoptosis, 
cultures were exposed to 500 nM Staurosporine (STS, Sigma-Aldrich), a protein kinase 
inhibitor, for 16 hours. Such experimental paradigm was chosen following a pilot study 
(see addendum 1). The same number of cells was plated, to evaluate differences in 
decreased cell density among control and NCL fibroblasts after treatment. For quantitative 
analysis, the number of cleaved caspase-3 positive cells and of fragmented nuclei were 
obtained after scanning under the microscope the seeded plates. For each cell line, figures 
of the remaining cells after STS treatment were compared to untreated cells and differences 
among cell population were given as percentage. 
 
BrdU incorporation assay 
To evaluate the proliferation of control and NCL affected fibroblasts, we carried out a 
BrdU incorporation assay. BrdU is an analogue of the dC nucleotide and is incorporated in 
DNA of cells during S phase of mitotic cycle. After 72h of culture on coverslips, cells were 
 35
exposed to 10 µM BrdU (Sigma-Aldrich) in complete medium for 5 hours and then fixed 
in Methanol at 4° for 10 minutes. DNA was denatured with 2N HCl  at 37°C for 1 hour, 
then the coverslips were neutralized in Na2B4O7 (0.1 M, pH 8.5), washed in PBS and 
blocked with 10% Normal Goat Serum for 30 minutes. Primary antibody incubation was 
performed over night at 4°C with monoclonal mouse α-BrdU (Sigma-Aldrich) in PBS with 
1% BSA and 0.5% Tween20. BrdU-labelled cells were visualized with Goat α-mouse 
Alexa Fluor 488 (Molecular Probes) and nuclei were counterstained with DAPI. 
Percentage of BrdU labelled cells was given as number of nuclei BrdU-positive on number 
of DAPI-staining nuclei. 
 
Statistical analysis 
Statistical significance were determined by t-student test analysis. A p value minor to 
0.05 was considered as significant, whereas a p value minor to 0.01 was considered as 
highly significant. 
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Addendum 1 
We performed a pilot study to determine the optimal conditions for Staurosporine 
treatment in order to assess possible differences in the activation of the caspase-3 
dependent apoptotic pathway between NCL and control fibroblast cultures. For this 
preliminary experiment, we employed a control (C2) and CLN1-1 cell lines at early 
passages of cultures (8th passage). Cells were seeded at the same density and after 72 hours 
were exposed to the apoptotic inducer at different conditions. The number of the cleaved 
caspase-3 positive cells and fragmented nuclei were counted after immunofluorescence 
assay and given as percentages on the remaining cellular population. Coherently, 
fragmented nuclei co-localized with the caspase-3 positive cell, so the percentages of 
caspase-3 positive cells and percentage of fragmented nuclei were homologous. For this 
pilot study, only one dish was counted, so we could not perform a statistical analysis. 
1 µM STS is usually employed to induce apoptosis in vitro. Previous works have already 
showed high values of cleaved caspase-3 enzymatic activity after both 8 and 16 hours 
treatment, using a STS concentration lower than 1 µM  (in particular 100 nM; Johanssonn 
et al, 2003).  Likewise, we decided to use a concentration minor to 1 µM in order to asses 
if NCL fibroblasts were more vulnerable to the caspase apoptotic cell death as compared to 
controls at low concentration of STS.  
For these reasons, we analyzed  control and CLN1 fibroblasts after exposure to 50 nM 
and 500 nM for 4, 8 and 16 hours. After 4 hours, fibroblasts changed their morphology and 
began to shrink, but no fragmented nuclei or cleaved caspase-3 positive cells were detected 
at this time (data not shown). 
After 8 hours, a significant cell density reduction was reported and low percentages of 
fragmented nuclei and apoptotic cells were measured, according to the different STS 
concentrations (figure 2). After 16 hours, the exposure to 50 nM STS induced low amount 
of apoptotic cells, whereas at the concentration of 500 nM higher percentage of fragmented 
nuclei and cleaved caspase-3 positive cells were evident.  
Therefore, this pilot study indicated that in our model the best STS treatment conditions 
were 16 hours exposure to a concentration of 500 nM. Indeed, using this paradigm, we 
were able to measure a significant percentage of fragmented nuclei and cleaved caspase-3 
positive cells and we could also analyzed the different cellular response between NCL and 
control lines, as regard the caspase-3 dependent apoptotic pathway.  
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Figure 2 .  
Apoptotic cell death investigation in NCL fibroblasts.  
A. After 4 hours of STS exposure dots of JC1 staining are present in the cytoplasm of shrunken 
CLN1-1 fibroblasts (left). At this time no fragmented nuclei are detected. After 16 hours of 
exposure to 500 nM STS, cleaved caspase-3 positive cells with fragmented nuclei appear (right). 
Nuclei were counterstained in blue with Hoechst (left) or DAPI (right); scale bars equal to 10 µm.  
B. Increased amounts of cleaved caspase-3 positive cells following STS treatment at different 
concentrations (50 and 500 nM)  and time exposure (8 and 16 hours).  Markedly evident different 
behaviour between control (C2) and CLN1-1 fibroblasts are evident at 500 nM STS concentration, 
following 16 hours of exposure. 
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6. RESULTS 
 
The first issue addressed in this thesis was the evaluation of the endo-lysosomal 
compartment behaviour along time, namely the differences among control cells and 
different NCL fibroblast lines. Then we investigated the process of autophagy, as a major 
mechanism of the cells to cope with the abnormal storage. The effects of abnormal storage 
on the mitochondrial reticulum and related functions was then examined even to search for 
evidences of apoptotic cell death in this experimental paradigm. 
 
THE ENDO-LYSOSOMAL COMPARMENT  
Cell behaviour as regard to the lysosomal bodies formation along time 
Control Fibroblasts 
At early passages, fibroblasts showed typical ‘spindle-shape’ profiles and had good 
proliferation ability. Lysotracker positive ‘dotted’ vesicles could be detected over the 
cytoplasm, both near nucleus and in the cell periphery (figure 3). The Lamp2 staining 
pattern and distribution resembled Lysostracker staining and indicated the presence of 
small lysosomal vesicles distributed in the cytoplasm of the cell. Moreover, the 
ultrastructural examination revealed that lysosomal structures were prevalently ‘electron-
dense’ lysosomal bodies, whereas only few single membrane empty vacuoles could be 
detected. At 15-18th passages, the staining pattern of the endo-lysosomal structures 
changed significantly. In particular, Lysotracker and Lamp2 immunofluorescence was 
enhanced and spread all over the cytoplasm, suggesting an increased density and 
distribution of these structures (figure 3 and 4). The expansion of the endo-lysosomal 
compartment affects directly the cellular morphology: several fibroblasts became larger, 
increased in size and lost their typical ‘spindle-like’ shape. In addition, the proliferation 
rate of these aged cultures decreased and cells grew slowly. The ultrastructural analysis, as 
expected, confirmed the increased amount of lysosomal organelles of different 
morphology, whereas only few vacuolated cells were detected. Thus, in the control 
fibroblasts the accumulation of lysosomal structures, the loss of characteristic shape and 
the reduced proliferation capability are the main features that characterized the prolonged 
growth of the control fibroblast and they are the cell morphological features related to the 
aging of these cultures.  
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NCL Fibroblasts 
The same morphological analysis was performed on different genetically determined 
NCL fibroblasts. NCL lines showed different behaviours of the lysosomal compartment 
according to time and NCL form.  
Lysotracker and Lamp2 immunofluorescence showed an expansion of the lysosomal 
Figure 3.   
Lysotracker staining of control and NCL lines during the prolonged culture.  
Punctated pattern is seen in control fibroblasts at early passages (A), whereas this pattern is diffuse 
over the cytoplasm at later stages (B). Conversely, the acidic compartment is diffusely and 
markedly stained in all NCL lines at early stages (C, E, G, I). At late passages, many cells appear 
swollen and even brighter, engulfed with endo-lysosomal material (D, F, H, J). Scale bar equal to 
20 µm; n: nucleus. 
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compartment and an abnormal distribution of lysosomal vesicles in NCL fibroblasts since 
the early passages (figure 3). In particular, Lysotracker and Lamp2 immunofluorescence 
suggested that many more lysosomal vesicles (as compared to controls) engulfed the 
cytoplasm of NCL fibroblasts, forming tightly related storages mainly in the perinuclear 
region. The engulfment with lysosomal material affected the cellular morphology; 
Lysotracker positive, swollen cells (particularly of specific NCL forms, such as CLN1, 
CLN3 and CLN7) could be observed since the early passages (figure 3). Along time this 
pattern became more evident, and at late passages the vast majority of NCL fibroblasts 
(independently from the form and the mutations) were swollen and overwhelmed by 
Lysotracker and Lamp2 positive structures. However, his phenomenon was always more 
evident in CLN1, CLN3 and CLN7 lines. Furthermore, CLN1 and CLN7 lines exhibited 
also a slowed growth, since the early passages, as detected by BrdU assay (data not 
shown). 
Even the ultrastructural pattern of NCL fibroblasts showed variations among the different 
NCL forms, and was markedly distinct from the features of control cells. Since the early 
stages of cultures, NCL fibroblasts were characterized by the accumulation of lysosomal 
bodies, often closely related to empty vacuoles lined by a single membrane (figure 4); this 
feature was more impressive in the CLN3, CLN6 and CLN5 lines. These vacuoles were 
mainly optically empty and it was not possible to determine their origin precisely. 
However, the detection of Lamp-2 positive large vesicles by immunofluorescence suggests 
that most of these vacuoles are of lysosomal nature. This mixture of vacuoles and 
lysosomal bodies localized prevalently near the nucleus, resembling the same distribution 
depicted by Lysotracker and Lamp2 fluorescence.  
Semiquantitative analysis of electron microscopy samples revealed a markedly increased 
evidence of lysosomes and dense bodies, which cannot be related to the cellular aging 
process of the cultures only. Furthermore, NCL fibroblasts in general exhibited a higher 
percentage of vacuolated cells as compared to controls, both at early and late passages of 
cultures. However, the behaviour of the NCL lines was not always homogeneous, because 
different patterns could be detected even within the same NCL form.  
Specifically, the three CLN1 lines seemed to share a common trend. During the early 
stages the amount of dense bodies was not particularly marked and they were similarly 
scattered in the cytoplasms of the three cell lines; their morphological features were similar 
to those of controls. Along time a steady increase in the lysosomal component was 
observed. A meaningful increase of vacuolated cells was seen (about 50% of cells were 
 41
vacuolated), and the amount of vacuolization increased similarly in the three cell lines. The 
size of empty vacuoles that characterized the aging of CLN1 cultures was similar to the 
size of the dense bodies. 
Different patterns of cytoplasmic changes occurred in CLN3, CLN6 and CLN5 cell lines. 
In general, in these NCL forms, the dimension of the empty vacuoles were larger as 
compared to those of CLN1. Moreover, another distinct feature was the high number of 
lysosomal bodies enclosing partially digested cytoplasmatic material (probably, 
autolysosomes), that were detected in lower amount in controls and CLN1 lines.  
Figure 4.   
Morphological analysis of the lysosomal compartment at 15th passage: Lysotracker staining (A, D, 
G, L), Lamp2 immunofluorescence (B, E, H, M) and electron microscopy (C, F, I, N). Blue 
fluorescence represents the Hoechst nuclear staining. Many NCL fibroblasts appear swollen and 
engulfed with fluorescent markers of endo-lysosomal compartment as compared to control. By 
electron microscopy, in NCL fibroblasts the lysosomal compartment appears to be made up of both 
vacuoles and lysosomal bodies. Scale bar for Lysotracker and Lamp2 images equal to 20 µm. 
Electron microscopy images were acquired at 3000x magnitude; scale bar equal to 1 µm. 
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As concern CLN3, both CLN3 lines showed high score of vacuolization at early 
observations, with a further increase of single cell vacuolization at later steps, whereas the 
marked increased of lysosomal bodies accumulation was seen of CLN3 -2 line only. The 
morphology of vacuoles in CLN3 fibroblasts were often associated with expanded 
endoplasmic reticulum cisternae. Moreover, double membrane structures, typical of 
autophagosomes, were detected in the cytoplasm of CLN3 -2 cell lines (figure 5). 
With regard to CLN6, all three cell lines showed a meaningful progression of cells 
having cytoplasmic lysosomal bodies from early to late stages of culture, as well as the 
number of cells showing heavy dense bodies accumulation increased too. Different trends 
were observed as far cytoplasmic vacuoles are concerned: two lines (CLN6 -1 and -3) 
showed meaningful increase of vacuoles along time, as well as increased the number of 
markedly vacuolated cells. On the contrary an opposite trend was observed in CLN6-2, 
where dramatic reduction of vacuolated cells occurred. Furthermore, dramatically enlarged 
vacuoles were observed at the early observation in CLN6-2 only, and this pattern, 
however, was never seen at later stages (figure 5). In addition, autophagosomes were 
detected in two CLN6 lines at different stages of cultures, at both time steps (CLN6 -2) or 
merely at late passages (CLN6 -3).  
Figure 5.   
Evidences of autophagy in CLN3 -2 (I and II) and CLN6 -2 (III and IV) at early passages. 
Ultrastructural detection of dramatically enlarged vacuoles (I and III) and double membrane 
autophagosome in the cytoplasm (arrows, II and III). Photos were acquired at 3000X (I and III) and 
50000X (II and IV) magnitude. 
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Finally, CLN5 resembled the trend of CLN6 -2, with dramatic increase in lysosomal 
bodies and decrease of vacuoles from the early to the late stages of cultures. In particular, 
at early passages many empty vacuoles, both large and small, were detected, whereas at 
late passages the accumulation of many autophagolysosome, enclosing partially digested 
material, was prevalent. 
 
Evidences of activated autophagic pathway 
The morphological analysis of the endo-lysosomal system suggested activation and 
expansion of this compartment in the NCL cultures. The presence of many single 
membrane vacuoles at different time of observations in all NCL cell lines, as well as the 
ultrastructural evidence of double membrane layered autophagosomes, led us to investigate 
whether the cytoplamic vacuolization might be indeed expression of activated autophagic 
pathway. Thus, we analyzed the expression of two different proteins involved in 
autophagy, the cytosolic LC3 I/LC3 II complex and the Atg12-Atg5 complex, by means of 
indirect immunofluorescence and western blot.   
Double staining with anti-LC3 and -Lamp2 antibodies revealed that many LC3 positive 
vacuoles were present in the cytoplasm of different NCL cell lines since early passages 
(figure 6 and table 3). Moreover, in the case of CLN3 -2 and CLN6 -2, the fluorescent 
Figure 6.  
Double immunofluorescence assay against Lamp2 (red) and LC3 (green) at early passages of 
culture. Nuclei are counterstained with Hoechst (blue). Lamp2 immunoreactivity fills the large 
majority of the cell body; LC3 II punctated fluorescence can be either independent from Lamp2 
signal (II and IV) or partially merged (co-localization in yellow signal, III). ‘Green’ circle 
structures – presumably LC3 lined vacuoles – are detectable (arrow, II). (I, control; II CLN1-3; III 
CLN3 -2; IV CLN6 -2). Scale bar equal to 20 µm. 
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evidence of autophagosome formation was supported by the detection of autophagosomal-
like structure at electron microscopy analysis (figure 5). On the other side, only few 
sporadic LC3 dots were detected in control cells. Moreover, many LC3 positive vesicles 
were detected also in the cytoplasm of CLN1 -3 and it was possible to see LC3 positive 
structures that resembled the morphology of vacuoles (figure 6, arrow).  
As expected, the Atg12-Atg5 complex was expressed in both control and NCL 
fibroblasts without significant differences both at early and late stages of cultures (figure 
7A).  
As regards the western blotting analysis of LC3 isoforms, at early passages control cells 
did not show LC3 II expression, whereas different NCL fibroblast lines exhibited both the 
Figure 7.   
A. Western blotting analysis of Atg12-Atg5 complex. The complex is expressed at same level in 
control and NCL fibroblasts, both at early and late stages of culture. 
B. LC3 western blotting analysis on controls (C1 and C2) and different NCL lines, both at early (9-
10th p) and late (16-18th p) stages of cultures. At early passages, LC3 II isoform is present, with 
different intensity, in CLN1 (lines 2 and 3), CLN3 -2, CLN6 -2, and CLN5, suggesting an 
activation of autophagic pathway in these NCL cell lines. At 16-18th passages LC3 II band is seen 
in control cells, is still present in CLN1 -3, CLN3 -2 and CLN6 -2, fades in CLN5 and is weakly 
present in CLN6 -3.  
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14 kDa and the 16 kDa bands (figure 7B). However, likewise the ultrastructural analysis of 
vacuoles and lysosomal bodies, NCL fibroblasts showed a heterogeneous behaviour in the 
expression of LC3 isoforms since differences among cell lines affected by the same NCL 
form could be found. In particular, CLN1-2 and CLN1-3 fibroblasts showed similar 
patterns of LC3 II expression (whereas no signal was seen in CLN1-1) (figure 7B). CLN6 -
1 and CLN6 -3 cells did not show expression of LC3 II, whereas high levels were detected 
on CLN6 -2. In addition, CLN3 -2 exhibited high level of LC3 II, whereas CLN3 -1 
showed a weaker signal. However, it is important to note that the western blot analysis of 
LC3 II always confirmed the detection of many LC3 positive vesicles following 
immunofluorescence assay in the same lines. Finally, the analysis on aged cultures showed  
LC3 II expression in control fibroblasts and differences as far as NCL cell behaviour. In 
CLN1 -3, CLN3 -2 and CLN6 -2 lines the pattern was still present, whereas the signal 
intensity decreased in CLN5 line. Eventually, the LC3 II isoform expression was never 
found in CLN3 -1 and CLN6 -2.  
Results of the LC3 immunofluorescence assay related to the signal intensity on western 
blot are summarized in table 3. 
 
 
 
 
 
Table 3.  
Immunofluorescence (IF) and western blotting (WB) analyses of LC3 expression, both at early and 
late stages of cultures. CLN1 -3, CLN3 -2 and CLN6 -2 show high level of this autophagic markers 
at both stages of culture. In general, the signal intensity of immunofluorescence assay resembles 
the intensity after immunoblotting analysis. (‘-’: no signal; ‘±’: poor signal; ‘+’: weak signal; ‘++’ 
intense and ‘+++’ highly intense signal; ‘nd’: not done) 
IF WB IF WB
C1 - + + +
C2 - - + +++
CLN1 -1 + + + -
CLN1 -2 ++ ++ + nd
CLN1 -3 ++ ++ ++ +++
CLN3 -1 nd + + -
CLN3 -2 +++ +++ +++ +++
CLN5 + ++ + +
CLN6 -1 nd - + -
CNL6 -2 +++ +++ ++ +++
CLN6 -3 + + + +
CLN7 ++ + ++ ++
Early Late
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THE MITOCHONDRIAL COMPARTMENT 
Relationship between lysosomal compartment and mitochondria network in NCL 
We hypothesized that the expansion of lysosomal structures in the cytoplasm of NCL 
fibroblasts could affect the distribution and functioning of the mitochondrial reticulum. 
The mitochondrial fluorescent probe Mitotracker was employed in association with 
Lysotracker in order to investigate the spatial relationship between mitochondrial and 
lysosomal compartments and to identify changes of mitochondria distribution due to 
abnormal lysosomal storage. The investigation of mitochondrial compartment was made 
principally at late stages of culture because previous date suggested that at 15th passage the 
engulfment by lysosomal structures was more severe. 
Mitotracker staining showed that in normal fibroblasts mitochondria are organized in a 
tubular network. This network is mainly distributed around nucleus, forming a tubular and 
regular reticulum. As concerned NCL fibroblasts, cells with intense Lysotracker staining 
and lysosomes accumulation showed a distortion of mitochondrial network, mainly in 
perinuclear regions where the lysosome storage was more severe (figure 8).  
Figure 8.  
Relationship between mitochondrial and lysosomal compartments at late stage of culture. Cell were 
exposed at the same time with Mitotracker (green) and Lysotracker (red) and counterstained by 
Hoechst (blue). I: the distribution of the mitochondrial reticulum through the cell body and 
processes; note punctuated Lysotracker staining in the perinuclear region. II: increased evidence of 
Lysotracker staining in the perinuclear region; a colocalized pattern is shown (yellow). III: the 
cytoplasm of a round cell is filled with red fluorescence; scanty Mitotracker staining can be 
detected in the peripheral processes. IV: even more intense lysosomal staining and stripes and 
filamentous pattern of mitochondrial staining at the cell periphery. (I control; II CLN1 -1; III CLN3 
-2; IV CLN7). Scale bar equal to 20 µm.     
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In addition, we tried to quantify this morphological alteration, identifying those cells that 
showed a fragmented or altered distribution of mitochondria after Mitotracker staining 
(figure 9). We found that the percentage of cells with altered mitochondrial network after 
15 passages was increased in NCL cultures as compared to control. CLN1 exhibited higher 
percentage as compared to control (66% for CLN1 -1 and 35% for CLN1-2 versus 10% for 
control cells). Moreover, also CLN1 -3, CLN5, CLN6 -1 and CLN6 -3 showed similar 
percentage of cells with distorted reticulum, that is higher than control ones. 
Mitochondrial density and lysosomal accumulation 
Following the fluorescent study of mitochondrial compartment, we performed an 
ultrastructural analysis in order to confirm the alteration of spatial mitochondria 
distribution within the NCL cytoplasm in relation with lysosomal structures. The EM 
analysis of fibroblast cultures confirmed that mitochondria distribution was strictly 
connected with the distribution of lysosomal structures. As described above, NCL 
fibroblasts, at 15th passage of culture, showed a remarkable amount of empty vacuoles and 
B 
0
10
20
30
40
50
60
70
%
 c
el
ls
 w
ith
 
al
te
re
d 
re
tic
ul
um
Mitochondrial reticulum alteration
1             2            3  
CLN1C
1             2            3  1             2  CLN5
CLN6
A 
Figure 9.  
A. Mitotracker staining of the mitochondrial compartment at late stages of culture. Mitochondrial 
reticulum appears distorted and fragmented in NCL fibroblasts, as depicted in insets (I control; II 
CLN1 -1; III CLN6 -1). 
B.  Semiquantitative analysis of mitochondrial reticulum at 15th passage. NCL lines show high 
percentage of cells with distorted reticulum as compared to controls, except for CLN6 -2. 
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lysosomal bodies, mostly located by the perinuclear region. Only a few mitochondria 
remained in the perinuclear area, whereas several of them could be detected at the cell 
periphery, as depicted for a CLN1 -2 fibroblast (figure 10A). To confirm that in NCL cell 
the lysosomal compartment might affect the distribution of mitochondria, we performed a 
semiquantitative analysis of mitochondria density. As shown in figure 10B, the number of 
mitochondria in perinuclear area was significant lower in 3 CLN1 and 3 CLN6 lines as 
compared to controls at the 16th passage in culture. In addition, we performed an 
immunoblotting analysis on cellular lysates from NCL and control fibroblasts in order to 
evaluate the ratio between the mitochondrial porin VDAC (the most abundant protein of 
mitochondrial outer membrane, which is considered as a quantitative marker of the cellular 
mitochondrial population; Rostovtseva and Bezrukov, 2008) and -tubulin. Since the early 
Figure 10.  
A. Distribution of mitochondria, represented as red dot, in control (C1) and CLN1 -1 lines (16th 
passage). Few mitochondria are detected in the perinuclear area in CLN1 cell as compared to 
controls. Photos were acquired at 3000X magnitude. 
B. Electron microscopy analysis of mitochondrial distribution in control and NCL fibroblasts in the 
perinuclear area (16th passage). The density of mitochondria per cell surface (100 µm2) is lower in 
different NCL lines, especially in CLN1 lines (** p< 0.001).  
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passages, this ratio was significant lower in NCL fibroblasts as compared to controls, 
particularly the CLN1 lines and the CLN7 line, suggesting that the mitochondrial density is 
really defective since early steps of culture (figure 11). A similar trend was evident also by 
using another mitochondrial protein, subunit IV of cytochrome c oxidase (COX IV). 
However, at late passage the difference in VDAC/tub ratio is less significant than at early 
passages due to the increased variability of control lines.  
JC1 staining and the distribution of polarized mitochondria in NCL fibroblasts 
In order to see if the modification of mitochondrial reticulum was related to a functional 
alteration of mitochondria in NCL fibroblasts, we investigated the mitochondrial 
membrane polarization state and the distribution of polarized mitochondria using JC1. By 
using this fluorescent probe, mitochondria with normal membrane polarization show 
yellow/red fluorescence, while damaged mitochondria with low Δm display green 
Figure 11.   
A.  Western blotting analysis of two mitochondrial markers, VDAC and COX IV, on control and 
NCL lines (early passages). 
B. Quantitative analysis of VDAC/α tubulin ratio. CLN1 and CLN7 exhibit significant reduction at 
early passages as compared to control, whereas no difference is found for CLN5 and CLN6 lines. 
At late passages, differences between cases and control are less significant. Values are reported as 
‘fold increase’ as compared to a control lysate. Histograms represent means ± deviation standard of 
at least two independent experiments on control and NCL lines (C: C1, C2, C3 and C4; CLN1: 
CLN-1, CLN1 -2 and CLN1 -3; CLN6: CLN6 -1, CLN6 -2 and CLN6 -3). Only one CLN5 and 
CLN7 lines were analyzed (* p<0.05; ** p< 0.01). 
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fluorescence. NCL fibroblasts exhibited a different distribution of polarized mitochondria 
as compared to control fibroblasts. In the early stage of culture, several NCL cells appeared 
swollen and the polarized mitochondria were shifted to the cell periphery, leaving a green-
staining perinuclear zone. At late stages, the number of swollen engulfed cells increased 
and the shift of polarized mitochondria become more evident. Only few polarized 
mitochondria remained in perinuclear region (figure 12). In addition, the pattern of 
polarized mitochondria was also different among control and NCL fibroblasts. In fact, in 
control cells it was possible to identify a tubular shape of red-staining polarized 
mitochondria, whereas in NCL fibroblasts polarized mitochondria appeared shorter and 
dotted. 
Respiratory chain activity in NCL fibroblasts 
In order to correlate the morphological changes with a possible functional impairment of 
mitochondria, we investigated the respiratory chain activity in different NCL lines at late 
stage of cultures. As regard the activity of complex II-III, the biochemical analysis 
revealed a significant reduction in CLN1 and CLN5 cell lines, whereas only CLN5 cell 
line had a decreased activity in the complex IV (table 4). No differences of complex I-III  
activity was detected among case and control fibroblasts. 
Figure 12 .  
Distribution of polarized mitochondria (red) in control and NCL fibroblasts at late passages. JC1 
staining shows that polarized mitochondria are delocalized to cell periphery in NCL fibroblasts (I 
control; II CLN1 -1; III CLN3 -1; IV CLN7). Few mitochondria remain in the perinuclear region, 
where the engulfment of lysosomal material is more severe. Nuclei were counterstained with 
Hoechst (blue). Scale bar equal to 20 µm.  
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Mitochondrial related apoptotic pathway under basal conditions and after STS exposure 
in NCL fibroblasts 
In addition to the study of respiratory chain activity, we tested whether the mitochondrial 
impairment in NCL fibroblasts might activate the mitochondrial-dependent apoptotic 
pathway, and therefore lead to cell death via apoptosis. Specifically, we investigated two 
main late steps of the caspase dependent apoptosis, cleavage of caspase-3 and nuclear 
fragmentation. In basal conditions, no fragmented nuclei were detected following both 
DAPI nuclear staining and ultrastructural analysis in both control and NCL fibroblasts. To 
test differences in vulnerability to cell death among control and NCL cells, we treated 
cultures with Staurosporine, an inhibitor of protein kinase C (PKC), able to trigger both 
caspase dependent and independent apoptotic pathway and to depolarize the mitochondrial 
membrane potential, which eventually leads to apoptotic cell death (Johansson et al 2003; 
Salvioli et al 2000). Following incubation with 500 nM STS for 16 hours, fibroblasts 
changed their morphology, became smaller and a significant number of fragmented nuclei 
and cleaved caspase-3 could be detected after immunofluorescence assay and western 
blotting analysis (figure 13A). The immunofluorescence quantitative analysis after 
exposure to STS revealed a different vulnerability among the different NCL forms at early 
passages (figure 13B and 13C). In particular, two CLN1 cell lines (CLN1 -1 and -2) 
showed an high percentages of cleaved caspase-3 positive cells as compared to controls 
(21 and 27.5 % against 8.1%; p< 0.001). On the other side, cell lines belonging to 
‘secondary’ lysosomal NCL forms (CLN5, CLN6 -2, CLN6 -3 and CLN7) showed similar 
level of apoptotic positive cells as compared to control. At late passages, the percentage of 
C CLN1 CLN5 CLN6
Complex I-III 54.23 ± 4.9 63.36 ± 17.18 39.07 ± 21.28 39.75 ± 27.02
Complex II-III 0.43 ± 0.14 0.22 ± 0.02 * 0.21 ± 0.11 * 0.23 ± 0.17
Complex IV 2.45 ± 0.73 1.56 ± 0.54 0.62 ± 0.15 * 1.27 ± 0.51
Table 4.  
Biochemical analysis of respiratory chain in control and NCL fibroblasts at late passages. Complex 
II-III activity was reduced in CLN1 and CLN5 lines, whereas complex IV was affected only in 
CLN5 line (* p< 0.05). No meaningful difference in complex I-III was found. Values are corrected 
for citrate synthase activity and reported as means ± standard deviation of at least two experiments 
on different controls and NCL lines (C: C1, C2, C3 and C4; CLN1: CLN1-, CLN1-2, CLN1-3; 
CLN6: CLN6-1, CLN6-2; only one CLN5 line was used).  
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fragmented nuclei and caspase-3 positive cells decreased also in the two CLN1 and no 
statistical significance between NCL and control lines was found (data not shown).  
Preliminary investigation on the cellular density reduction associated with the activation 
of caspase-3 induced by STS did not provide evidence of meaningful decreased cell 
density among CLN1 and control cell lines. Furthermore, similar findings were obtained 
from the same experimental approach to the other CLN forms. 
Figure 13 .  
Apoptotic cell death investigation in NCL fibroblasts.  
A. After 16 hours of exposure to 500 nM STS, cleaved caspase-3 positive cell with fragmented 
nucleus (inset) could be detected in CLN1 -2 cell line. The presence of cleaved caspase-3 was 
confirmed by western blotting analysis in control and NCL lines (early passages). 
B and C. Percentage of cleaved caspase-3 positive cells after STS exposure (500 nM for 16 hours), 
as measured by immunofluorescence assay (early passages). A significant percentage of caspase-3 
positive cells was found on CLN1 -1, CLN -2 and CLN7 cell lines (* p < 0.05; ** p < 0.001).  
Control values were reported as means ± deviation standard of 2 experiment in triplicate on 2 
different controls, whereas means of a triplicate experiment were reported for the different NCL 
lines.  
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7. DISCUSSION 
The aim of this doctorate project was to set up a pathogenetic study in vitro, using human 
NCL cell lines. In particular, we used fibroblast cultures established from patients affected 
with different genetically determined NCL forms, with either ‘primary’ (CLN1) or 
‘secondary’ (CLN3, CLN5, CLN6 and CLN7) lysosomal involvement. These cell lines 
were analyzed in a ‘prolonged culture paradigm’ with the aim of studying the cellular 
behaviours that might be triggered in this stressful condition.  
The main topic of this project was to investigate the evolution of the endo-lysosomal 
compartment during the long-lasting growth of NCL cells, and possibly shed light on the 
putative mechanisms which underlie the cell death mechanisms in these diseases. 
As expected, the cytoplasmic distribution of lysosomal markers was associated with the 
ultrastructural evidence of remarkable increase of lysosomal elements (as compared to 
controls). Furthermore cells from all NCL forms showed steady increased of cytoplasmic 
empty vacuoles, most of them of lysosomal origin, whereas for other vacuolated figures 
the precise origin was not identified. The recognition of classical ultrastructural elements 
(such as the double membrane autophagosome, or the single membrane autolysosome) led 
us to realize the process of autophagy to be active in this in vitro model. The progressive 
decline of growth rate since the early passages, particularly evident of CLN1 and CLN7 
cultures, was consistent with some energy dysfunction of the cell. And some results were 
in accordance with the involvement of the mitochondrial compartment, possibly due to the 
mechanical damage secondary to cytoplasmic engulfment by the storage. 
 
Evolution of the endo-lysosomal system during the prolonged growth  
Aging of control fibroblast cultures was associated mainly with changes in cellular 
morphology, loss of the typical ‘spindle-like’ shape and a progressive mitotic rate decline. 
Together with these features, Lamp2 immunofluorescence and Lysotracker staining 
showed an expansion of the endo-lysosomal compartment, a “physiological” feature of 
aging in cultured cells. The prolonged culture of NCL fibroblasts showed several 
similarities as compared to controls, but the features of the aging process appeared to occur 
earlier and to be more intense. Furthermore, different behaviours could be observed among 
the NCL forms, which might account for the specific effects on the cell of the mutated 
genes (and associated malfunctioning proteins), as well as of the specific growth features 
of each cell line. 
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The ultrastructural analysis of the endo-lysosomal compartment allowed us to identify 
qualitative differences in the typology of the storage material accumulating during the 
prolonged culture among the NCL forms. In CLN associated to mutations of genes coding 
for protein unrelated to the hydrolytic functions of the lysosomes (such as CLN3, CLN5,  
CLN6) increasing amount of lysosomal bodies was associated with the formation of large 
vacuoles. In CLN1, which is considered as a “primary” lysosomal disorder, the 
ultrastructural pattern was different, due to the early and persistent presence of smaller 
empty vacuoles, which matched that of dense bodies.  
Furthermore, we found evidences in NCL fibroblasts of figures consistent with steps of 
autophagy, such as autophagosome formation, fused double membrane autophagosome 
with lysosomes, and lysosomal structures, either filled with electron dense material 
(autophagolysosome), or optically empty (empty vacuoles). And again different findings 
were found among the different forms, and these findings were partly confirmed by the 
biochemical investigations.  
Three CLN1 lines shared a common behaviour as regards the increasing amount of 
empty vacuoles from early to late passages. Moreover, LC3 II was expressed in similar 
way in CLN1-2 and CLN1-3 and in a weaker manner in CLN1-1, both after 
immunofluorescence and western blot analysis. These findings, together with the Lamp2 
and Lysotracker increased signal, suggested that the autophagic process may be activated 
in similar manner in the CLN1 lines, regardless the kind of gene mutations. The increased 
amount of empty vacuoles at late passages and the relative lower increasing in lysosomal 
bodies accumulation aroused the question of the meaning of autophagy in this condition. 
Moreover, it is important to keep in mind that there are no evidence of autophagy in CLN1 
biopsies in vivo. Thus the activation of the autophagic response in our in vitro model 
probably represents a transient adaptive behaviour of cells to cope with the storage of 
undigested lysosomal material. 
On the other hand, CLN3, CLN5 and CLN6 exhibited different behaviours as compared 
to CLN1 and controls; indeed, it was possible to differentiate two main patterns. CLN3-2, 
CLN6-2 and CLN5 showed evidences of an intense autophagic response, both at early and 
late steps of this process. In particular, autophagosomes (as well as empty vacuoles and 
autophagolysosomes) were detected in the cytoplasm and this finding was supported by 
high expression of LC3 II after both immunofluorescence and western blot assays. 
Moreover, these cell lines shared a common ultrastructural pattern, featuring decreased 
vacuolization and increased lysosomal bodies storage from early to late passages of 
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cultures. Conversely, CLN6-1 and CLN6-3 were marked by lower level of LC3 II 
expression at western blot analysis and an increasing vacuolization from early to late 
passages, even if autophagosomes were detected on CLN6 -3 cells at late passages. In 
CLN3-1 vacuolization and dense bodies formation was never associated with evidence of 
LC3 I to LC3 II conversion.   
Taking together, these findings suggested that the autophagic process was activated in 
our in vitro model, unrelated to either specific NCL form or severity of mutation. At early 
passages, this phenomenon was expressed with a intensity gradient among the different 
NCL cell lines, and it was particularly evident on CLN3 -2 and CLN6 -2 (figure 14). 
Moreover, in the same cell lines, it was a long lasting process detectable even at late 
observations both ultrastructurally and biochemically. Vacuolization occurred early in 
those lines of NCL which are known to have vacuolated cells in vivo (such as CLN3 and 
CLN6), whereas its onset was later in CLN1 (which are not associated with vacuole 
formation in vivo). Nevertheless, despite a wide vacuolization of the cytoplasm in many 
NCL cell, we could not find evidence of autophagic cell death.  
A possible interpretation of these events is far to be near. One might argue that in CLN3, 
CLN6, CLN5 (or at least in some cell lines according this experimental settings) autophagy 
is necessary for the process of lysosomal storage (and possible degradation) of the products 
which accumulate due to the genetic defect. As to the question whether the persistence of 
autophagy will provide advantages to the cells, or it will exert negative effects because it 
keeps on going out of control (even to possible cell death) no answer is possible right now. 
In fact, autophagy has been recently related to different human pathologies, including 
neurodegenerative disorders (Levine and Kroemer, 2008). Moreover, autophagic 
Figure 14.   
Intensity gradient of LC3 expression in different NCL lines, represented for western blotting (WB, 
upper part) and immunofluorescence analyses (IF, lower part) at early passages. As regard IF, a 
score related to the amount of LC3 vesicles was given (‘-’ and ‘±’: no or few LC3 positive vesicles; 
‘+’ and ‘++’: several and many LC3 positive vesicles; ‘+++’ high amount of LC3 positive vesicles; 
‘?’: not tested). This graph derived from figure 5, figure 7 and table 3. 
C1 C2 CLN3 -1 CLN6 -1 CLN1 -2 CLN1 -3 CLN5 CLN3 -2 CLN6 -2CLN1 -1CLN6 -3
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impairment has been linked to LSD, on the assumption that a lysosomal defect may 
interfere with the normal autophagy process of the cell. Thus, evidences of autophagic 
impairment, such as increased LC3 II level and autophagosomes accumulation, have been 
described on MSD, MPS-IIIa and GM1 mouse brain samples (Settembre et al, 2008; 
Takamura et al, 2008). With regard to NCL, CLN3 was considered as the main NCL form 
in which autophagy is activated because of the detection of large vacuoles on peripheral 
lymphocyte and other tissues. Recently, this condition was also found on biopsies of CLN6 
patients (Cannelli et al, 2009) whereas no evidence of autophagy on CLN1 has been 
reported in vivo so far. However, opposite conclusions have been drawn by studies on a 
murine models of CLN3. In the CLN3ex7/8 knock-in mouse disruption of autophagy is 
suggested at level of autophagic vacuolar maturation (Cao et al, 2006), whereas in such as 
cathepsin knock-in mice results show an active role of the autophagy process in the 
abnormal storage accumulation (Koike et al, 2005).  
In conclusion we think that autophagy is activated in NCL cells, probably as a rescue 
process to cope with enhanced lysosomal storage. However, as far as those cell lines which 
show long lasting evidence of LC3 I  LC3 II conversion, one might argue that the 
switching off of autophagy is impaired, and that such condition might hamper the cell 
survival, whereas decline of LC3 II signal as well as vacuole formation might represent a 
good outcome for those cell lines, in which autophagy has been down-regulated (or 
switched off) and empty vacuoles represent the efficacy of the storage-degrading 
machinery. Which signals trigger the autophagic response and keep it on-going (or turning 
it down) is a matter of future investigations. 
 
 
Mitochondrial involvement 
Several previous studies have demonstrated that mitochondria exhibit morphological and 
functional alterations both in human and animal NCL fibroblast cultures. In particular, 
ovine CLN6 fibroblasts showed alterations of ATP synthase activity in different ‘energy 
demand’ conditions, whereas human CLN1 fibroblasts exhibited reduced ATP synthase 
activity as well as an impaired activity of the complexes II-III and IV of the respiratory 
chain (Das et al, 1999; Jolly et al, 2002). Enlarged mitochondria with abnormal cristae 
were also described in neurons of English setter dog (Jolly et al, 2002). Results from this 
study have given some structural evidences to these previous findings, and particularly it 
has been shown that CLN1 lines were affected in all the experimental settings. The 
mitochondrial reticulum appeared to be distorted and fragmented in CLN1, CLN5, CLN6 
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cell lines in the perinuclear region, where the accumulation of vacuoles and lysosomal 
bodies was more severe. Furthermore the topological involvement of the mitochondrial 
network was also supported by the evidences that polarized mitochondria where 
redistributed to the periphery as well as by a reduction in mitochondria density. Eventually, 
in CLN1, reduction of mitochondrial porine VDAC (on quantitative western blot analysis) 
was again consistent with a reduction of mitochondrial mass in the cell lysates, as it was 
supported by the ultrastructural semi-quantitative analysis, which also revealed the shift of 
mitochondria distribution from the perinuclear region to the cell periphery.  
Evidences of mitochondrial fragmentation has been reported in other LSD models, such 
as β-gal -/- mouse astrocytes and MLIV human fibroblasts (Takamura et al, 2008; Jennings 
et al, 2006). The influence of  lysosomal impairment on the fission and fusion processes of 
mitochondrial reticulum has not been clearly determined so far. However, in these models 
the morphological alterations in mitochondrial reticulum were related to an impaired 
functionality, such as in Ca2+ buffering capacity (Takamura et al, 2008). However, in our 
in vitro model, the morphological alterations and the reduced density of mitochondrial 
compartment that occur during the prolonged cultures did not seem to induce a meaningful 
functional impairment, as demonstrated by the slight respiratory chain involvement for 
CLN1  and CLN5 fibroblasts.  
Which might be the implications for the neurons of such “secondary” involvement of the 
mitochondrial compartment? One issue might relate these findings to the known increased 
vulnerability of the neurological behaviour of children affected with any NCL form to 
energy-requiring conditions, such as the fever; likewise enhanced seizure activity observed 
in similar conditions might be related to decreased efficiency of inhibitory mechanisms to 
prevent convulsions. Furthermore distal degeneration of the long axons is observed in 
LSD, and that can be related to the mechanical obstacle to axoplasmic flow by the storage. 
If one takes into account that axonal flow dynamics are energy-dependent processes, any 
kind of mitochondrial dysfunction might hamper the bidirectional exchanges along the 
axonal length, which necessary for and depending from the good being of the cellular 
bioenergetic mechanisms.  
A possible role of mitochondrial dysfunction has been also investigated in this thesis, 
namely its possible relationship with the cell death mechanisms. Several studies have 
already suggested a contribution of apoptosis in cell death, which occurs in human CLN1 
and CLN2 (Riikonen et al, 2000, Hachiya et al, 2006). In both human and murine CLN1 
caspase-mediated apoptosis was demonstrated to occur following ER stress and 
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mitochondrial membrane destabilization secondary to oxidative stress (Kim et al, 2006, 
Zhang et al, 2006, Wei et al, 2008). Conversely, overexpression of PPT1 protects 
neuroblastoma cell lines from induced apoptosis (Cho et al, 2000). Likewise the product of 
CLN8 (whose mutations lead to a late-infantile variant form of NCL) seems to protect 
hippocampal neurons and human neuroblastoma cell lines from the NMDA-induced 
apoptosis, because both gene silencing and transfection with mutated cln8 clones increased 
the percentage of apoptotic cells after the NMDA exposure (Vantaggiato et al, 2009).   
We could not find any evidence of the apoptotic activation, such as cleaved caspase-3 
and fragmented nuclei following immunofluorescence, western blot and EM analyses 
under basal condition, in any cell line. On the contrary evidence of apoptosis was obtained 
after inducing mitochondrial mediated cell death, by treating fibroblasts with STS, a 
protein kinase inhibitor which induce apoptosis by Cathepsin D translocation to the 
cytosol, followed by cytochrome c release and caspase activation (Johansson et al, 2003). 
In fact, there was a meaningful increased percentage of fragmented nuclei and caspase-3 
positive cells in two CLN1 lines (figure 13), as compared to controls and the other NCL 
forms. This phenomenon was evident only at early passages, whereas no significant 
differences were obtained with aged fibroblasts. These findings are in agreement with the 
previous evidences that apoptosis is not a process common to all human NCL forms, but 
that it is limited to selected forms only, such as CLN1. Moreover, the evidence of a 
possible relationship among ER and oxidative stresses, mitochondrial membrane 
permeabilization and apoptosis may provide elements of further investigations as far as to 
target these phenomena with specific drugs (e.g. anti-oxidants), in order to slow down and 
ameliorate the disease progression, in CLN1 at least.  
  
Conclusions and perspectives 
In conclusion, the culture model employed in this study provided several information 
about the pathogenic mechanisms that could be involved in NCL, at least in vitro. Indeed, 
the expression of LC3 II, the detection of autophagosomes and single membrane vacuoles, 
both empty and with indigested material, in the cytoplasm of most of NCL cell lines 
demonstrated an involvement of the autophagic pathway. The presence of empty vacuoles 
is not per se a clue of autophagic response under way but it suggests that this process 
might be unable to evolve in a physiological manner. These results supported the idea that 
autophagy may be involved in the pathogenesis of NCL, as already demonstrated in cln3 
and cathepsin deficient mice (Koike et al, 2005; Cao et al, 2006). However, our findings 
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suggested that in this in vitro model activation of autophagy might be considered as an 
adaptive mechanism by which cells try to cope with the enhanced lysosomal activity rather 
than a direct cell death mechanism. Certainly, the role of autophagy in NCL deserves a 
more detailed investigation, in order to better characterize, for instance, the dynamics of 
this process in NCL, such as the alteration of the ‘autophagic flux’ in basal conditions and 
after modulation by chemical inducers and/or blocker (Mizushima et al, 2010). Moreover, 
the major goal will be to find out which signals regulate the activated autophagy, either as 
an effective rescue mechanism or as a condition which collaborates with storage 
engulfment of the cells. Thus, we can hypothesize that the study of the autophagic 
involvement in NCL could have a direct impact on the planning of hypothetical treatments 
of this disorders, that are not available so far. For instance, one might argue that if the NCL 
forms with prolonged survival showed a ‘better’ autophagic response as compared with the 
most severe forms, the modulation of the autophagic pathway could have likely a direct 
clinical implication.  
Moreover, an interesting facet emerged from the autophagic study was the formation of 
empty vacuoles. The nature of these structures, that were present in high amount in the 
cytoplasm of many NCL cell lines, seemed to be of lysosomal origin, but how and which 
cellular compartments they arise from remain to be clearly elucidated. Preliminary 
observations suggested a possible relation between expanded ER cisternae, vacuoles and 
autophagy and, therefore, the role of ER in NCL will be investigated in detail. 
In addition, we have also demonstrated that the mitochondrial compartment may be 
secondarily involved in NCL. Moreover, the apoptotic study outlined a different 
vulnerability to STS between CLN1 and other NCL forms. Certainly, the cell death 
mechanism need more exhaustive studies to assess clearly distinct behaviours among the 
different NCL forms. It is noteworthy that fibroblasts are not so prone to undergo to 
apoptosis and this could be an important drawback of this in vitro model when compared 
to neuronal cell. However, the role of apoptosis in NCL has been recently revaluated. The 
deletion of Bax on cathepsin D mouse fails to protect the animal from neurodegeneration 
(Shacka et al, 2007); in addition, over-expression of Bcl-2 or knock out of p53 do not 
modify the lifespan of CLN2 -/- mouse model (Kima et al, 2009). These findings imply that 
the apoptotic pathway does not explain per se the neurodegeneration that occur in NCL 
and that other mechanisms could be involved in the disease progression. Moreover, murine 
CLN1 and CLN2 fibroblast are apparently more resistant to TNF-induced apoptosis (Tardy 
et al, 2009, Autefage et al, 2009). Thus, our results support the idea that in NCL other 
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factors than apoptosis could be involved in the pathogenesis and in cell death. We wonder 
if the autophagic impairment and a slight mitochondrial involvement could represent 
‘chronic’ negative events that might enhance the vulnerability of neuronal cells to the 
storage-related stress, thus contributing to their fatal outcome. 
Finally, we can state that the prolonged growth paradigm employed in this study was 
very useful to elucidate several pathological facets that occur in NCL fibroblast cultures. 
We are confident that this in vitro study could be applied to other lysosomal storage 
diseases, in order to elucidate behavioural similarities and/or differences between NCL and 
other LSD fibroblast cell lines. On the other side, we were aware of the limitation to use 
fibroblasts in the investigation of NCL, a group of diseases which affects the CNS 
primarily. However, the pathological study employed in this thesis could be translated to 
other experimental models, such as primary neurons cultures and neuroblastoma cell lines 
in order to investigate, for instance, the impact of autophagic dysfunction in neuronal cells. 
Moreover, also the study of vertebrate models, such as caenorhabditis elegans or 
zebrafish, could be generate new insights into the pathological changes in NCL. In 
particular, the use of genetically modified animal models could allow to investigate the 
changes which affect the CNS during the aging process, in the same as we have analyzed 
fibroblasts in the long-lasting growth paradigm.  
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